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ABSTRACT 
Bisphenol A (BPA) exposure has recently become a public health 
concern, and the safety of the utilization of BPA has attracted the attention of the 
scientific community, politicians, and the general population. Although BPA is 
banned from baby products in a few countries because infants and young 
children are particularly susceptible to endocrine disruption, recent studies have 
consistently indicated the association between urinary BPA concentration and 
cardiovascular diseases in adults. Therefore, adult exposure to this xenoestrogen 
is becoming a healthcare issue that cannot be ignored. We selected large 
conductance Ca2+/voltage sensitive potassium (BK) channels as one of the target 
proteins for BPA effects because the function and expression of BK channels are 
regulated by estrogen. Additionally, BK channels play an important role in 
vascular function and changes in BK expression are associated with disease. We 
hypothesized that BPA would differently affect BK channel function and 
expression via separate non-genomic and genomic mechanisms. The goals of 
our studies were 1) to characterize a novel, membrane-permeable, and 
economical antagonist called penitrem A to facilitate the study of BK channels, 2) 
to determine the mechanisms by which BPA increases BK channel activity and, 
3) to determine the mechanisms by which BPA reduces vascular BK channel 
expression. 
Current from patches of HEK 293 cells transfected with hSlo α or α + β1 
were blocked >95% by penitrem A (IC50 6.4 vs. 64.4 nM; p<0.05). Further, 
penitrem A inhibited BK channels in inside-out and cell-attached patches, 
whereas iberiotoxin could not. Inhibitory effects of penitrem A on whole-cell K+ 
currents were equivalent to iberiotoxin in canine coronary smooth muscle cells. 
Penitrem A enhanced sensitivity to K+-induced contraction in canine coronary 
arteries by 23 ± 5% (p<0.05) and increased the blood pressure response to 
phenylephrine in anesthetized mice by 36 ± 11% (p<0.05). 
In cultured canine coronary artery smooth muscle cells (CASMC), acute 
BPA (10 µM) exposure increased BK channel currents 179 ± 8% (p<0.05).  
Inside out recordings from native canine CASMCs showed that acute BPA 
increased BK channel open probability (Po) from 0.11 ± 0.03 to 0.47 ± 0.09 at 
+40 mV (p<0.05). HEK cells transfected with BK α subunits alone were 
insensitive to acute BPA (currents at +100 mV were 101 ± 13% of control) while 
acute BPA increased BK channel currents by 53 ± 12% (p<0.05) when cells were 
transfected with α and β1 subunits. Similarly, single channel recordings indicated 
NPo was 123 ± 20% of control in the BK α subunits alone with BPA, however, 
acute BPA increased NPo 201 ± 41% in patches from cells expressing BK α and 
β1 subunits. Thus, BK β1 subunits facilitated BPA-induced BK channel activation 
and the effects of BPA were non-genomic, as these effects were observed in 
cell-free patches.  
In contrast to the acute effects of BPA on BK channel activity, 48-72 hrs of 
BPA (10 µM) exposure decreased BK channel expression in A7r5 cells and 
cultured rat aorta. Western blot data indicated that BK α subunit protein content 
was 33 ± 8% of control in BPA-treated aorta (p<0.05). Patch clamp recording 
showed that whole cell current densities at +100 mV were 57 ± 7% lower in aortic 
SMC treated with 10 µM BPA (p<0.05) while whole cell current densities from 
aortic SMC treated with BPA + ICI 182780 (100 nM; an estrogen receptor 
blocker) were not different (101 ± 14% of control). Penitrem A-sensitive current 
densities at 100 mV were 53.9 ± 14.8, 12.0 ± 3.0, and 48.4 ± 10.1 pA/pF in 
DMSO, BPA and BPA + ICI 182780, respectively (p<0.05). Thus, chronic BPA 
exposure decreased BK channel expression by estrogen receptor mediated 
signaling.  
Our data indicate: 1) penitrem A is an economical alternative to iberiotoxin 
for BK channel analysis; 2) acute BPA exposure activates BK channel activity 
and BK β1 subunits play a role in BPA induced BK channel activation; 3) chronic 
BPA exposure decreases vascular BK channel expression via estrogen receptor-
dependent mechanisms. Although acute BPA exposure activates the BK channel 
through a non-genomic mechanism that could be beneficial for heart due to 
coronary dilation, longer BPA exposure decreases the number of functional BK 
channels through a genomic mechanism that could be detrimental to the heart. 
Thus, the overall effect of BPA exposure on vascular function may be harmful 
due to disruption of BK channel-mediated vascular regulation. Taken together, 
these results indicated BPA induced altered BK channel function and expression 
may be one of the mechanisms for the association between BPA exposure levels 
and cardiovascular diseases seen in epidemiological studies. 
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SPECIFIC AIMS  
Scientific and technological advances provide a variety of chemicals for 
tremendous benefit; however, concerns have been raised regarding 
environmental exposure to xenoestrogens that disrupt endocrine function. 
Recent data suggest that the effect of estrogen on cardiovascular physiology is 
far more complicated than previously envisioned. Because we do not fully 
understand the function of estrogen in cardiovascular health and disease, it is 
difficult to predict the effects of xenoestrogens and endocrine disruptors on 
cardiovascular physiology. One estrogenic endocrine disruptor, bisphenol A 
(BPA), holds enormous financial and practical importance for plastic 
manufacturers, but issues surrounding its safety create concern. A recent 
epidemiological study associated urinary BPA levels with cardiovascular 
diseases including angina, atherosclerosis, and myocardial infarction(Lang et al., 
2008). Mechanistic data regarding effects of BPA on the cardiovascular system 
are scarce; therefore, we do not yet understand how BPA could be linked to 
coronary heart conditions. BPA acts on nuclear estrogen receptors (ER) to 
mediate genomic effects, while non-genomic effects of BPA appear to originate 
at the cell membrane. Membrane targets for BPA remain unclear, but include the 
G protein-coupled estrogen receptor (GPER30; (Thomas & Dong, 2006)) and ion 
channels (Choi et al., 2007). Importantly, there are no data available regarding 
the effect of BPA on the function and expression of ion channels in vascular 
smooth muscle cells (VSMC), a cell type involved intimately in angina, 
atherosclerosis, and myocardial infarction. 
 xii 
Large conductance Ca2+/voltage-sensitive K+ (BK) channel is an excellent 
model for studying non-genomic effects of BPA, because its activity is estrogen-
sensitive (Valverde et al., 1999; Dick & Sanders, 2001). The BK channel is also 
an excellent model for studying genomic actions of BPA, because the underlying 
gene, KCNMA1, is regulated by estrogen (Kundu et al., 2007). BK channels are 
highly expressed in VSMC, possess the regulatory β1 subunit (Tanaka et al., 
1997), and regulate coronary vascular tone (Ledoux et al., 2006; Borbouse et al., 
2009). Our long-range goal is to identify molecular mechanisms by which 
estrogenic chemicals affect vascular function. Our objective in this application is 
to determine mechanisms by which BPA modulates BK channel expression and 
function. The central hypothesis is that BPA alters BK channel expression and 
function through separate genomic and non-genomic mechanisms. The rationale 
is that receptors for BPA exist at both the cell membrane and in the nucleus. To 
test the central hypothesis and achieve the objective, we propose 2 specific 
aims: 
 
1. Determine the non-genomic mechanism by which BPA increases BK 
channel activity in VSMC. The working hypothesis is that BPA increases BK 
channel activity by binding to an extracellular site on the channel that is 
comprised, at least in part, of the regulatory β1 subunit. Patch clamp studies will 
be performed on VSMC using a derivative of BPA that we have synthesized. 
BPA-monosulfate (BPA-MS) is permanently charged, membrane-impermeable, 
and will be used to determine on which side of the membrane the binding site 
 xiii 
resides. The role of the β1 subunit will be determined using cloned BK channels 
composed of α or α + β1 subunits. 
 
2. Determine the genomic mechanism by which BPA decreases BK channel 
expression in VSMC. The working hypothesis is that BPA reduces BK channel 
expression by activating nuclear ER. Western blots will be used to determine the 
expression level of BK channels in VSMC treated with BPA. The pure ER 
antagonist Fulvestrant (ICI 182,780) and BPA-MS will be used to determine the 
involvement of nuclear and membrane ER in BPA-induced reductions of BK 
channel protein expression. 
 
We expect, at the completion of this project, to define mechanisms by which BPA 
increases BK channel activity and reduces BK channel expression in VSMC. 
Knowing the mechanisms of action of BPA on VSMC will aid interpretation of 
correlative studies regarding BPA exposure and human health. The proposed 
work is innovative because it addresses both genomic and non-genomic effects 
of BPA related to ion channels, VSMC, and cardiovascular disease. 
 xiv 
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CHAPTER 1 Background and significance 
Overview of BPA 
BPA exposure and health concerns 
BPA is used to manufacture products including polycarbonate plastic, the 
resin inside of cans, dental sealants, and as a non-polymer additive to other 
plastics. Since BPA is a versatile material, over 6 billion pounds are produced 
each year, and over 100 tons are disposed of on the earth (Vandenberg et al., 
2009). BPA, which possesses estrogen mimetic properties, has recently become 
the subject of much interest and attention. BPA is public health concern due to 
exposure in the environment, and a possible association with several 
pathological conditions. According to the National Health and Nutrition 
Examination Survey (NHANES) conducted during 1988-1994, BPA was detected 
in over 95 % of population (Calafat et al., 2005). Newer data collected during 
2003-2004 also supports the initial finding of widespread human BPA exposure 
(Calafat et al., 2008). Notably, the geometric mean of BPA exposure from 2003-
2004 NHANES (2.6 µg/L) was twice as large as the one from 1988-1994 (1.33 
µg/L). These data may suggest that BPA exposure is continuously increasing 
over the years.  
Currently, the U.S. Food and Drug Administration (FDA) and the U.S. 
Environmental Protection Agency (EPA) state the reference dose; a daily 
exposure to the human population that is likely to be without an appreciable risk 
of deleterious effect during a lifetime, of BPA is 50 µg kg-1 day-1. Importantly, 
there is continuing controversy whether this current acceptable daily intake level 
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is an appropriate estimate for the safe level. A number of recent studies are 
suggesting the possible low dose effect of BPA, which may involve totally newly 
mechanisms that alter cellular functions. Furthermore, many studies have 
detected BPA in urine, blood and tissue; however, the levels of BPA exposure 
are controversial. BPA has been shown to accumulate in adipose tissue (Nunez 
et al., 2001; Fernandez et al., 2007) so that the local BPA concentration in tissue 
could be higher than the values reported in total blood BPA concentration. 
Furthermore, cumulative BPA exposure levels may play a role in BPA associated 
pathologies. Additionally, this reference dose was calculated based on a 
toxicological experiment to determine the lowest observed adverse effect level 
(LOAEL) in the 1980’s. Thus, there is a desperate need for updated data 
regarding BPA’s toxicological aspects. 
Although there is no clear consensus of adverse health effects from BPA, 
the large body of evidence suggested that BPA possesses endocrine disrupting 
activities in a tissue specific manner. Specifically, BPA may be associated with 
altered fetal/neonatal development (Vandenberg et al., 2007), reproductive 
function (Savabieasfahani et al., 2006), metabolic homeostasis (Hugo et al., 
2008) and carcinogenesis (Wetherill et al., 2002; Wetherill et al., 2005). Thus, the 
U.S. Food and Drug Administration (FDA) and National Toxicology Program 
(NTP) at the National Institute of Health state that they have “ some concerns 
regarding the potential effect of BPA on the brain, behavior, and the prostate 




Toxicodynamics / toxicokinetics of BPA 
BPA is a lipophilic molecule that contains 2 phenol rings, which resembles other 
toxic chemicals such as diethylstilbestrol (DES) and 
dichlorodiphenyltrichloroethane (DDT) (Fig. 1-1). These compounds were 
banned due to their endocrine disrupting properties and have been associated 
with an increased risk of tumor development (Vandenberg et al., 2009). Similarly, 
one of the well-known chemical properties of BPA is an estrogenic property that 
interacts with estrogen receptors (ERs) to activate estrogen signals. 
Conventionally, it is known that endocrine disrupters act via nuclear estrogen 
receptors as 17 β-E2 acts on ERs, however, the mechanisms of non-genomic 
effects such as the involvement of membrane receptors or ion channels are not 
well established. Indeed, xenoestrogens were reported to be much less potent 
than 17 β-E2 (Krishnan et al., 1993; Kuiper et al., 1997). Recent studies have 
demonstrated that the nongenomic action of BPA may be associated with altered 
intracellular Ca2+ homeostasis (Nadal et al., 2000; Alonso-Magdalena et al., 
2005; Walsh et al., 2005). Yet, the exact mechanisms of BPA induced alterations 
remain unknown. Given that BPA has a low affinity for binding with classical 
nuclear receptors; it is possible that non-genomic effects of BPA may play an 
important role in BPA associated altered cellular function in addition to classical 
genomic ER signaling disruption. 
In terms of BPA toxicokinetics, studies have been shown that the half-life 
of BPA in the blood range from 4 to 6 hours in humans (Volkel et al., 2002; Volkel 
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et al., 2005). Considering the studies demonstrating that the half life of BPA in 
the blood is a relatively short time, and the studies showing the detection of BPA 
from urine samples in over 90% of population (Calafat et al., 2005; Calafat et al., 
2008), the environmental BPA exposure to humans must be continuous. 
Alternatively, it is possible that BPA can be stored in the body and constantly 
released into the blood. Indeed, toxicological studies have shown that BPA 
accumulates in brown adipose tissue in rats (Nunez et al., 2001) and BPA and its 
derivatives were detected in the adipose tissue of women (Fernandez et al., 
2007). Since there are no doubts about the prevalence of BPA in our body, 
further research is needed to explore the pharmacokinetic/dynamics of BPA and 






Figure 1 1 Chemical structures of E2 and xenoestrogens and related 
compounds. 
 
Structures of 17β-estradiol and endocrine disruptors are shown. The structure of 
BPA is very similar to Dichlorodiphenylene (DDE) and Diethylstilbestrol (DES). 
DDE is a metabolite of DDT, which was banned as a pesticide due to its 
carcinogenic properties. DES is a pharmaceutical estrogen that was also banned 







Figure 1 2 Chemical reactions to release BPA from polycarbonate products. 
 
BPA molecule is released from polycarbonate products by the hydrolysis of the 
ester bond. The chemical reaction is facilitated during certain conditions, 





Sources of BPA 
Although BPA has been detected in a variety of sources including food, 
beverages, air, soil, and house dust, the major BPA exposure source was 
considered through dietary ingestion (Miyamoto & Kotake, 2006; Wilson et al., 
2007). Particularly, BPA has been shown to leach from polycarbonate 
compounds such as plastic containers and canned food. The initial report of BPA 
being released was in an accidental experiment showing that an estrogenic 
substance was suspected of leaching from autoclaving solution in polycarbonate 
flasks (Krishnan et al., 1993). As in all general chemical reactions, hydrolysis of 
ester bonds in polycarbonate products is facilitated at high temperature and pH 
levels (Fig. 1-2). Examples commonly seen in our lives may be washing a plastic 
container with harsh detergent, or heating it, or storing acidic/basic food in it. 
Indeed some of these conditions are shown to release BPA (Brotons et al., 1995; 
Kang et al., 2003).  
Interestingly, a recent study reported that the BPA levels did not decline 
with fasting conditions in human subjects (Stahlhut et al., 2009). This study may 
suggest that the oral route may not be the only route of BPA exposure. 
Additionally, BPA has been shown to be stored in adipose tissue (Nunez et al., 
2001; Fernandez et al., 2007), therefore, cumulative BPA levels may also need 
to be considered when the source of BPA exposure needs to be determined. 
Taken together, there are no doubts about human BPA exposure; however, the 
exact source of BPA is not known. It is likely to be multiple sources responsible 
for human BPA exposure.  
 8 
BPA and cardiovascular diseases 
In 2008, an initial epidemiological study demonstrated a significant 
relationship between urinary BPA concentration and cardiovascular diseases in 
the general adult population from the United States (Lang et al., 2008a). This 
cross-sectional analysis utilized data from the National Health and Nutrition 
Examination Survey 2003-2004 and the data indicated higher BPA 
concentrations were associated with cardiovascular diagnosis, diabetes, and 
altered liver enzyme levels. Later, newer data from the NHANES 2005-2006 also 
appeared consistent with an association between urinary BPA concentration and 
cardiovascular disease (Melzer et al., 2010). Additionally, high levels of BPA in 
serum were associated with atherosclerotic plaques in the aged population (Lind 
& Lind, 2011). Occupational levels of BPA exposure also have been associated 
with an increased risk of male sexual dysfunctions such as erectile dysfunction 
(Li et al., 2010). Although government agencies have concerns due to BPA’s 
potential harmful effects on fetuses, infants and young children, these studies 
may suggest that BPA toxicity is not limited to the specific population but rather, 
a global effect to all populations.  
All taken together, BPA has become a public health concern only in the 
last few years, and many controversies exist about routes of exposure, the 
quantity we are exposed to, mechanisms of BPA action, and its associations with 
diseases (Vandenberg et al., 2009). Since constant BPA exposures are 
suspected and therefore this phenomenon will continue to intensify, early and 
conclusive studies for safety are extremely important to prevent public health 
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hazards like the ones that have been created by the use of materials such as 
asbestos and dichlorodiphenyltrichloroethane (DDT).  
 
Overview of ion channels in VSM 
Ion channel and toxicological compounds 
Ion channels are macromolecular protein complexes that form pores in 
cell membranes, which regulate the movement of ions. The membrane potential 
determined by these ion channels are critical, since excitable cells utilize 
electricity for communication between the extracellular side and intracellular side 
to further propagate intracellular signal transduction to trigger a cellular response. 
(i.e. Ca2+ flux). Thus, ion channels located in the membrane make very 
convenient targets for altering cellular function. As shown in nature, many toxins 
(i.e. tetrodotoxin, iberiotoxin, charybdotoxin) are designed to alter ion channel 
functions, and are used as predators’ weapons to establish a dominant world 
where the strong prey upon the weak. Furthermore, the disruption of membrane 
integrity by forming transmembrane pores (gramicidin, amphotericin, nystatin,) is 
also a great example of how important the ion channel is in the membrane to 
regulate ionic gradients between extracellular and intracellular spaces. In other 
words, ion channels may be susceptible to toxicological chemicals.  
 
Potassium channels in VSMC 
The primary function of VSMC is contraction, as in other muscle types 
such as skeletal and cardiac muscle. Calcium dependent muscle contraction 
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obeys the basic principle of excitation-contraction coupling (ECC) which explains 
the membrane excitability and intracellular Ca2+ concentration that regulates 
muscle contraction. As in other muscles, the two key players in ECC are voltage 
dependent L-type Ca2+ channel (Cav1.2) and ryanodine receptor (RYR) in the 
VSMC. Similar to other muscles, voltage dependent L-type Ca2+ channels are 
activated by membrane depolarization resulting in Ca2+ flux through extracellular 
component to increase global intracellular Ca2+ concentration (Moosmang et al., 
2003). Therefore, ion channels contributing to the dynamic regulation membrane 
potential (Em) are key factors for VSMC contraction (Nelson et al., 1990). 
Particularly, K+ channels are important molecules in negative feedback 
mechanisms to set the resting membrane potential since the equilibrium potential 
of K+ are more negative than the resting membrane potential. Multiple types of K+ 
channels are identified in VSMC: 1) Inward rectifying K channel (Kir), 2) ATP 
sensitive K+ channel (KATP) 3) Voltage dependent K+ channels (KV), and 4): 
Calcium dependent K+ channels (KCa) (Holdefer et al., 1976; Nelson & Brayden, 
1993; Quayle et al., 1997; Dick & Tune, 2010). These potassium channels in 
VSMC, that provide hyperpolarizing currents, play a critical role in maintaining 
the resting membrane potential, and each type of K+ channel has its own unique 
biophysical properties.  
 
Kir and KATP channels 
Both Kir and KATP channels are categorized in the same phylogenetic tree 
and have been shown to express in vascular smooth muscle (Kubo et al., 2005). 
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The structure of the Kir family is composed of 2 transmembrane domains termed 
M1 and M2 with pore forming H5 regions that serves as ion selectivity filters 
(Bichet et al., 2003). Functional properties of Kir currents in VSMC were 
characterized by patch clamp recording (Edwards & Hirst, 1988; Edwards et al., 
1988). Patch clamp recordings demonstrated strong inward rectifying barium 
sensitive currents and increasing extracellular [K+] increased the conductance. In 
terms of the physiological role of Kir channels in VSM, moderate increases in the 
extracellular [K+] (3-20 mM) have been shown to cause vasodilation through a 
mechanism depending on Kir channel activation in cerebral arteriole (Girouard et 
al., 2010). In VSMC, Kir2.1 transcript was detected, but not Kir2.2 and Kir2.3 from 
rat cerebral, coronary and mesenteric arteries (Bradley et al., 1999). To support 
this gene expression data further, functional data also indicated that the cerebral 
artery from Kir2.2 KO mice responds to extracellular K+, but not the cerebral 
artery from Kir2.1 KO mice (Zaritsky et al., 2000). Thus, this molecular and 
functional evidence suggests that vascular Kir channels are composed of Kir2.1.  
On the other hand, KATP channels are composed of Kir6.1 and Kir6.2 with 
unique subunits known as sulfonylurea receptors (SUR). As in the Kir2.1 subunit, 
Kir6.1 and Kir6.2 subunits are composed of 2 transmembrane domains, M1 and 
M2, without voltage sensor domain such as S4 segment, thus KATP channel 
currents are not voltage dependent. Nonetheless, SUR subunits serve as the 
intracellular ATP binding site to regulate KATP channel. Although human coronary 
endothelial KATP channel has been shown to express as a heteromeric complex 
of Kir6.1, Kir6.2 and SUR2B, it was not demonstrated in human coronary artery 
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smooth muscle cells (Yoshida et al., 2004). Indeed, human coronary artery 
smooth muscle cells expressed Kir6.1, Kir6.2 and SUR2B mRNAs, however, a 
heteromeric complex of Kir6.1 and Kir6.2 was not confirmed as in the human 
coronary endothelial cells. In contrast, another study showed only Kir6.1 and 
SUR2B mRNA expression (Miura et al., 2003). These molecular biological data 
are further supported by the functional data that demonstrate that the aortic 
vascular responses to KATP channel agonists/antagonist (pinacidil, diazoxide and 
glibenclamide) are not different between wild type and Kir6.2 KO mice (Suzuki et 
al., 2001). Thus, this molecular and functional evidence suggests that the 
vascular KATP channel is composed of Kir6.1 and SUR2B. In terms of the 
physiological role of KATP channel in VSM, it has been suggested that KATP 
channel plays an important role in ischemic vasodilation (Dart & Standen, 1995). 
This is because the SUR regulatory subunits serve as the sensor for intracellular 
ATP levels and the KATP channel is generally inhibited due to sufficient levels of 
ATP under normal physiological conditions. KATP channel is also activated by the 
G-protein mediated cAMP dependent protein kinase (PKA) (Standen & Quayle, 
1998). For instance, adenosine induced vasodilation involves adenylyl cyclase-
cAMP-PKA pathways to activate KATP channel.  
 
KV channels 
KV channels are one of the most diverse potassium channels. Although 
they are classified into KV1- KV12 subfamilies and each subfamily contains 
several isoforms, the expression of KV1, KV2, KV3, KV4, KV7 and KV9 channel 
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subfamilies have been confirmed in vascular smooth muscle.  (Gutman et al., 
2003; Wulff et al., 2009). KV channel is composed of pore forming alpha subunits 
that can be homotetramers or heterotetramers of different families. The α subunit 
contains 6 transmembrane domains and the S4 segment serves as a voltage 
sensor. The S5-S6 linker and P-loop form the outer funnel and pore in KV 
channels. The K+ selective filter allows K+ ions go through the pore using the 
highly selective dehydration of K+ ions (MacKinnon, 2003).  In addition, KV 
channels have been suggested to contain auxiliary β subunits that can regulate 
the channel function. Although the exact molecular composition of KV channel is 
not clear because the composition of KV channels seem to be different 
depending on the vascular beds, KV channels are likely to be composed of 
heteromultimeric KV α subunits with diversity of β subunits that enables the 
formation of a variety of KV channels to response to appropriate physiological 
demand in the vessels (i.e. conduit vs resistance). For instance, KV α subunits 
(KV1.1, KV1.2, KV1.4, KV1.5, KV1.6, KV2.1 and KV9.3) are expressed in rat 
pulmonary arterial smooth muscle cells (Yuan et al., 1998), while KV α subunits 
(KV1.1- KV1.8 except KV1.4) are expressed in canine coronary artery (Dick et al., 
2008). Interestingly, within the diverse family of KV genes, some KV genes are 
particularly important in vascular function. Specifically, a mutant KV1.5 gene 
overexpression caused endogenous functional KV channels to switch 
dysfunctional KV channels due to the incorporation of mutant KV1.5 (Chen et al., 
2006). This dominant negative approach resulted in altered myogenic response 
and membrane potential in the vessels.  
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BK channel  
Large conductance Ca2+/voltage- activated K+ (BK) channels are expressed in 
variety of tissues and involved in variety of cellular process including circadian 
rhythms (Meredith et al., 2006) vascular regulation (Nelson et al., 1995; Brenner 
et al., 2000), hearing function (Pyott et al., 2007). BK channels are composed of 
4 α subunits encoded by KNCMA1 gene with auxiliary β subunits encoded by 
KCNMB1-4 genes. Although a single gene encodes the α subunit, it undergoes 
alternative splicing processes to yield several splicing variants that have diverse 
channel characteristics (Butler et al., 1993; Tseng-Crank et al., 1994). As a 
schematic BK channel structures are shown in Fig. 1-3, the α subunit contains 7 
transmembrane segments (S0 to S6) with N-terminus located at the extracellular 
side and C-terminus located at the intracellular side. Similar to other voltage 
sensitive K channel families, S4 segment serves as a voltage sensor to regulate 
BK channel opening/closing states (Cui & Aldrich, 2000). 
In addition to the voltage regulation, there are Ca2+ sensor sites similar to 
EF hand motif located at cytoplasmic C-terminal tail side. Furthermore, currently, 
there are 4 auxiliary β subunits encoded by KCNMB1-4 genes identified and 
each β subunit provides further unique BK channel properties. Specifically, first β 
subunits are isolated from smooth muscle membrane and identified as β1 subunit 
(Knaus et al., 1994a). The role of the β1 subunit is allosteric regulations of BK 
channel by improving the sensitivity to voltage and intracellular Ca2+ (Fig. 1-4) 
(Carl & Sanders, 1989; Cox et al., 1997; Cox & Aldrich, 2000). Thus, BK channel 
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β1 subunits have been suggested to play a key role in regulation of vascular tone 
(Brenner et al., 2000) and urinary bladder function (Petkov et al., 2001). It also 
regulates the functional surface expression of α subunits (Toro et al., 2006). 
Furthermore, β1 subunit-dependent BK channel activation was reported with 
steroid hormones (Valverde et al., 1999; Lovell et al., 2004; King et al., 2006; 
Bukiya et al., 2007). β2 subunits are expressed inn adrenal gland and 
hippocampal neuron and it uniquely causes inactivation of BK channel currents 
(Solaro & Lingle, 1992; Hicks & Marrion, 1998; Wallner et al., 1999). The 
expression of β3 subunit is confirmed in testis, pancreas and spleen and it 
causes a rapid inactivating BK channel currents (Xia et al., 2000). β4 subunits 
are primary expressed in brain and presence of β4 subunits make BK channel 
insensitive to iberiotoxin (Meera et al., 2000). In summary, β subunits alter Ca2+, 
voltage and chemical agonists/antagonists sensitivities. 
The primary role of BK channel has been suggested to act as negative 
feedback mechanism to regulate the opening of L-type voltage gated Ca2+ 
channels in vascular smooth muscle cells by voltage and intracellular Ca2+ levels 
(Fig. 1-5). Ca2+ spark, local increase in subsarcolemmal Ca2+, is coupled with BK 
channel activity, causing hyperpolarizing membrane potential to counter 
vasoconstriction (Nelson et al., 1995). Although BK channel mediate relaxation of 
arterial smooth muscle by Ca2+ sparks is evident in cerebral artery (Nelson et al., 
1995), recent data suggest the heterogeneity in the contribution of BK channels 
in vasculature tone in vascular beds (Yang et al., 2009). Thus, the physiological 
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role and the mechanism of BK channel activation may be far more complex and 




Figure 1 3 Molecular structure of BK channel α subunit and β1 subunit. 
 
The schematic diagram shows the key amino acid residues involved in 
modulation of BK channel. + indicates activation of BK channel and – indicates 







Figure 1 4 Dual regulation by Ca2+ and voltage on BK activity.  
 
(A) BK channel activity is plotted against voltage and Ca2+ concentration. (B) G-V 
relationship shifts toward the left as intracellular Ca2+ concentration increases 





Figure 1 5 The function of BK channel in vascular smooth muscle cells. 
 
Ca2+ spark activates BK channel and causes membrane hyperpolarization due to 
K+ efflux. This membrane hyperpolarization blocks L-type Ca2+ channel to 
decrease the global Ca2+ concentration levels in cytosol. BK channel regulates 




BK channel and vascular pathologies 
Aging, hypertensive and diabetic vascular BK channels 
In vascular smooth muscle cell, local intracellular Ca2+ increase can 
paradoxically induce smooth muscle relaxation. This is explained by the 
activating of the vascular BK channel that results in membrane hyperpolarization 
(Nelson et al., 1995). Therefore, BK channel has been recognized as one of the 
key molecules for vascular tone in a variety of vessels. Indeed, alterations in BK 
channel expression in vascular smooth muscle is associated with hypertension, 
aging, and diabetic related altered vascular functions in variety of vascular beds 
(Liu et al., 1997; Liu et al., 1998; Marijic et al., 2001; Lu et al., 2005; McGahon et 
al., 2007; Lu et al., 2008; Borbouse et al., 2009) 
Specifically, cerebral artery smooth muscle cells from genetically 
hypertensive rats exhibited over 4-fold higher BK channel current density and BK 
α subunits expression compared to Wistar-Kyoto rat cerebrovascular smooth 
muscle cells (Liu et al., 1998). Similarly, hypertension-induced increased BK 
channel has been demonstrated in aortic smooth muscle cells from 
spontaneously hypertensive rats (Liu et al., 1997). Hypertension induced 
increased BK channel expression is considered compensatory mechanism to 
counteract the increased cerebral vascular tone.  
On the other hand, age associated altered vascular ion channel 
remodeling indicated decreased BK channel function as age increased (Toro et 
al., 2002). Specifically, both rat and human coronary artery smooth muscle cells 
have been shown to decrease in BK current density and α subunits protein 
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content over time (Marijic et al., 2001). Additionally, age associated reduced BK 
channel β1 subunits and the mechanisms of aged associated reduced BK 
channel current density were reported later (Nishimaru et al., 2004a). 
Interestingly, a study has demonstrated that age associated decreased BK 
channel function has been attenuated by exercise training (Albarwani et al., 
2010). Therefore, age associated BK channel dysfunction is not an irreversible 
phenomenon, and therapeutic benefits can be expected from exercise or 
pharmacological approaches. Surprisingly, decreased BK channel expression 
with aging was not evident in aged cerebral artery smooth muscle cells 
(Nishimaru et al., 2004b). Thus, BK channel remodeling mechanisms 
compensate for age associated dysfunctional vasculature depending on the 
particular vascular bed, and they could be great pharmacological targets.   
Diabetes and metabolic syndrome related to vascular dysfunction is 
associated with altered BK channel function (Dimitropoulou et al., 2002; Lu et al., 
2005; Zhou et al., 2005; Burnham et al., 2006; McGahon et al., 2007; Borbouse 
et al., 2009). Some studies indicate that alterations in signaling mechanisms, 
such as arachidonic acid mediated signaling, result in impaired BK channel 
function, but not BK channel expression (Dimitropoulou et al., 2002; Lu et al., 
2005). Other studies demonstrate that BK channel biophysical properties 
including channel kinetics, sensitivities to voltage, and Ca2+ are impaired with 
diabetic vessels (Burnham et al., 2006; Lu et al., 2008). On the other hand, 
altered BK channel expression in diabetes has also been reported (McGahon et 
al., 2007; Borbouse et al., 2009). Based on these multiple levels of observation, 
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diabetes and metabolic syndrome associated altered vascular BK channel 
function is associated with the combination of altered BK channel upstream 
signaling, biophysical properties of BK channel and BK channel expression.  
 
Issues in studying BK channels 
BK channel antagonists/agonists 
In addition to wide expression of BK channel in human tissue, the 
numbers of chemical factors including ethanol (Dopico et al., 1998), hormones 
(Valverde et al., 1999; Lovell et al., 2004; King et al., 2006) and xenoestrogens 
(Dick et al., 2001; Coiret et al., 2007) have been shown to modulate BK channel 
function. Particularly, ethanol is often used as a solvent for a variety of drugs and 
it requires careful control for assessment of BK channel function when ethanol is 
used for vehicle of the drug. Common experimental approaches to assess the 
role of BK channel are pharmacological and genetic manipulation, however, each 
approach possess a limitation. 
A traditional pharmacological approach has been utilized to study the role 
of BK channel in physiological function before the gene disruption technology 
was established. Since the identification of peptide toxin including charybdotoxin 
(ChTX) and iberiotoxin (IBTX) (Miller et al., 1985; Galvez et al., 1990) from 
scorpion venom, both peptide toxins have been used to study the role of K+ 
channels in physiological function. Particularly, IBTX has been used as the gold 
standard to elucidate the physiological role of BK channel as well as the 
mechanism of gating because IBTX is highly selective to BK channel where 
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ChTX is sensitive to other type of K+ channels (Galvez et al., 1990). Although 
IBTX is recognized as a gold standard for BK channel inhibitor, several 
limitations exist. Originally, the potency of IBTX to BK channel was reported as 
IC50 pM to nM ranges (IC50 250 pM: (Galvez et al., 1990)), (IC50 1.7 
nM:(Kaczorowski et al., 1996), however, a recent study has shown the IC50 of 
IBTX is much higher (371 nM) (Lippiat et al., 2003) than the concentrations 
commonly used to assess the physiological role and biophysical properties of BK 
channels. Furthermore, IBTX is prohibitively expensive and its membrane 
impermeable characteristics make IBTX difficult to use in whole animal studies.  
Recently, a group of indole diterpenes has been reported as potent BK 
channel inhibitors (Knaus et al., 1994b); which gave a hope to overcome some of 
the limitations of IBTX, however, the pharmacological properties of each 
compound seem to be distinctive and have not been fully explored. For instance, 
some of these mycotoxins are tremorgenic indole alkaloids, but some are 
nontremorgenic such as paspalinine (Knaus et al., 1994b). Within a group of 
these mycotoxins, inhibitory effects of paxillne in BK channel have been relatively 
well characterized (Sanchez & McManus, 1996). In the original report of the 
effect of indole diterpenes on BK channel (Knaus et al., 1994b), it was mentioned 
that paxilline weakly blocks delayed rectifier potassium channels in mouse 
pancreatic β cells. Furthermore, paxilline has been reported to block Ca2+ 
activate Cl- channels (Sones et al., 2009). Penitrem A is also one of a group of 
tremorgenic mycotoxins that have been shown to affect the central nervous 
system by altering the release of neurotransmitters (Norris et al., 1980). The 
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ingestion of penitrem A has been associated with neurological disorders such as 
tremor, ataxia and convulsions in dogs and humans (Eriksen et al.; Lewis et al., 
2005), However, in terms of the effect on BK channels, very little data regarding 
the effect of penitrem A on BK channel and on vasculature tone are available. 
A few BK channel agonists have been identified and characterized by 
patch clamp experiments. For instance, NS004 (1-(2-hydroxy-5-chlorophenyl)-5-
trifluoromethyl-2- benzimidazolone) has been shown to increase open probability 
of BK channel and its open dwell time (Olesen et al., 1994b). Additionally, the 
effects of NS 1619 on BK channel have been well characterized (Edwards et al., 
1994; Olesen et al., 1994a) and utilized as well accepted BK channel opener in a 
variety of studies. Although NS 1619 has been utilized as a BK channel agonist, 
the issues in the selectivity of NS 1619 have been reported (Holland et al., 1996). 
It has been shown that NS 1619 not only activates BK channel, but also inhibits 
L-type Ca2+ channel activity. Therefore, it requires careful interpretation in 
vasodilation response when NS1619 is used for the analysis of BK channel 
function.  
 
BK channel KO mice 
As a recent subject of experimental popularity, the genetic modification 
approach has become the major experimental design; however, there are certain 
limitations to this approach, such as compensatory alteration to accommodate a 
gene disruption (Faraci & Sigmund, 1999). Indeed, constitutive BK α subunit KO 
mice and smooth muscle specific BK α subunit KO mice exhibit different degrees 
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of compensatory proteomic adaptions that resulted in more severe disruption in 
urinary bladder function from smooth muscle specific BK α subunit KO mice 
(Sprossmann et al., 2009). Furthermore, inter-laboratory variability exists in 
experimental results using other transgenic mice. For instance, BK β1 subunit 
KO mice were originally reported as hypertensive (Brenner et al., 2000; Pluger et 
al., 2000) but a recent study contradicted these original reports (Xu et al., 2011). 
Thus, although the utilization of BK channel KO mice in experiments is 
increasing, a combination of traditional pharmacological approaches to inhibit or 
activate BK channel to elucidate a role of BK channel in physiological and 
pathophysiological conditions is critical.  
 
Significance of study 
Although there is no clear consensus on the adverse health effects of 
BPA, evidence suggests that BPA may be associated with variety of pathologies 
including carcinogenesis, altered reproductive function, and developmental 
issues (Wetherill et al., 2005; Savabieasfahani et al., 2006; Vandenberg et al., 
2007; Hugo et al., 2008). Fetuses, infants, and children are more susceptible to 
effects of BPA; however, a recent epidemiologic study revealed that BPA 
exposure might be related to cardiovascular disease in adults (Lang et al., 
2008b). Because BPA exposure is increasing and these phenomena will 
continue to intensify, early and conclusive studies on safety and mechanism are 
needed to prevent public health hazards like the ones created by asbestos and 
DDT. This project will generate meaningful data useful to the Food and Drug 
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Administration and the National Toxicology Program in assessing BPA toxicity 
and providing regulatory guidance. Since possible links between BPA and 
disease have appeared relatively recently, controversies and confusion exist 
regarding its health effects. There is not enough scientific evidence to draw an 
accurate conclusion as to whether BPA exposure is linked to cardiovascular 
disease; however, alterations of BK channel function and expression are 
associated with coronary dysfunction related to hypertension (Brenner et al., 
2000; Amberg & Santana, 2003), diabetes (Lu et al., 2008; Borbouse et al., 
2009), and aging (Nishimaru et al., 2004a). Our contribution will be a detailed 
analysis of cellular and molecular effects of BPA on BK channels of vascular 
smooth muscle cells. We will elucidate molecular pharmacological and 
toxicological effects of BPA on BK channels; specifically, we will identify genomic 
and non-genomic mechanisms of BPA effect on BK channels in vascular smooth 
muscle cells.  
 
Summary  
In conclusion, although BPA has been utilized in industry because original 
toxicological studies conclude that the level of exposure to human is below the 
levels of observed adverse effect, recent studies raised concerns regarding the 
association with BPA and a number of pathologies. We hypothesize that BPA 
can alter BK channel function and expression via genomic/non-genomic 
mechanisms. With regard to our hypothesis, we also raised the issues in studies 
assessing the function of BK channel. Thus, we will characterize the new BK 
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channel inhibitor, penitrem A, and utilize penitrem A to identify the novel 
mechanisms of BPA induced altered BK channel function. These alterations may 
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Abstract 
Large conductance, Ca2+/voltage-sensitive K+ (BK) channels are well 
characterized, but physiological roles, often determined through pharmacological 
manipulation, are less clear. Iberiotoxin is considered the “gold standard” 
antagonist, but cost and membrane-impermeability limit usefulness. Economical 
and membrane-permeable alternatives could facilitate the study of BK channels. 
Thus, we characterized the effect of penitrem A, a tremorgenic mycotoxin, on BK 
channels and demonstrate utility for studying vascular function in vitro and in 
vivo. Whole-cell currents from HEK 293 cells transfected with hSlo α or α + β1 
were blocked >95% by penitrem A (IC50 6.4 vs. 64.4 nM; p<0.05). Further, 
penitrem A inhibited BK channels in inside-out and cell-attached patches, 
whereas iberiotoxin could not. Inhibitory effects of penitrem A on whole-cell K+ 
currents were equivalent to iberiotoxin in canine coronary smooth muscle cells. 
As for specificity, penitrem A had no effect on native delayed rectifier K+ current 
in canine coronary smooth muscle, cloned human KV1.5 channels, or pinacidil-
induced relaxation of canine coronary arteries. Penitrem A enhanced sensitivity 
to K+-induced contraction in canine coronary arteries by 23 ± 5% (p<0.05) and 
increased the blood pressure response to phenylephrine in anesthetized mice by 
36 ± 11% (p<0.05). Our data indicate that penitrem A is a useful tool to study the 
role of BK channels in vascular function and is practical for cell and tissue (in 
vitro) studies as well as anesthetized whole animal (in vivo) experiments.  
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Introduction 
Large conductance, Ca2+/voltage-sensitive (BK) channels, composed of 
pore forming α and auxiliary β1 subunits, may be key regulators of arterial tone 
via negative feedback (Nelson et al., 1995; Jaggar et al., 2000). Indeed, altered α 
or β1 expression is associated with vascular dysfunction in hypertension, 
diabetes, and aging (Liu et al., 1998; Brenner et al., 2000; Amberg et al., 2003; 
Borbouse et al., 2009). Genetic deletion of α or β1 subunits produces 
hypertension; however, in addition to presumed changes total peripheral 
resistance, the role of adrenal BK channels to regulate aldosterone production 
must also be considered (Cysewski et al., 1975; Sausbier et al., 2005). In 
contrast to the original report (Brenner et al., 2000), a recent study indicated that 
β1 knockout mice are normotensive (Xu et al., 2011). Thus, much remains to be 
determined about the physiological roles of BK channels and/or compensations 
in response to BK channel gene deletion. 
Adding complexity to our understanding of BK channel function is 
heterogeneity between vascular beds (Yang et al., 2009). While BK channels 
appear extremely important in regulating cerebral vascular tone (Brayden & 
Nelson, 1992; Knot et al., 1998), these channels are arguably less important in 
skeletal muscle arteries (Kotecha & Hill, 2005; Yang et al., 2009) or coronary 
arteries (Rogers et al., 2006; Borbouse et al., 2010a; Borbouse et al., 2010b). 
Clearly, the regulation of BK channels is extremely complex and governed by 
multiple endogenous signaling molecules (Hou et al., 2009). Thus, understanding 
the physiological roles and mechanisms of BK channel activation will require 
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additional research using a combination of genetic models and pharmacological 
tools. 
Since the identification and characterization of peptide toxins in scorpion 
venom, iberiotoxin has become the “gold standard” for pharmacological study of 
BK channels due to selectivity and potency (IC50 0.25 nM) (Galvez et al., 1990). 
However, a recent study determined the IC50 of iberiotoxin is much higher (33-
371 nM) than the concentrations commonly used (Lippiat et al., 2003). 
Additionally, iberiotoxin is prohibitively expensive for many isolated organ and 
whole-animal studies and its membrane-impermeability creates difficulty for cell-
attached or inside-out patch clamp experiments. It would be beneficial to identify 
an economical and membrane-permeable alternative to facilitate physiological 
and pharmacological studies of BK channels. Penitrem A is one such candidate 
molecule (Knaus et al., 1994) and has been used previously as an inhibitor of BK 
channels in smooth muscle (Cotton et al., 1997; Borbouse et al., 2009; Asano et 
al., 2010). 
Little, however, is known about the basic pharmacological properties of 
penitrem A. For example, the IC50 for block of BK channels has not been 
published, nor are there reports of its specificity in regard to other K+ channels. 
Our study was designed to characterize some pharmacological properties of 
penitrem A as a BK channel antagonist and to demonstrate utility in determining 
the physiological role of BK channels in vascular smooth muscle. Experiments 
were performed at the cell, tissue, and whole animal level. We used patch clamp 
techniques to assess the inhibitory effect, determine whether the β1 subunit 
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influenced block, and illustrate advantages of a membrane-permeable inhibitor. 
We measured the isometric tension of coronary arteries and the blood pressure 
of anesthetized mice to determine whether penitrem A altered vascular reactivity 
in vitro or in vivo. We conclude that penitrem A, compared to iberiotoxin, is an 
antagonist of BK channels that is comparable in potency and efficacy, but is 





All animal procedures and protocols were approved by institutional committees 
and followed guidelines set forth in the Guide for the Care and Use of Laboratory 
Animals (National Academy Press, 2011). Male C57BL/6 mice 10-12 weeks of 
age were used for in vivo blood pressure experiments. As described below, mice 
were anesthetized to a surgical plane of anesthesia prior to experiments and 
euthanized thereafter. Coronary arteries from male mongrel dogs were used for 
in vitro isometric tension experiments as described previously (Rogers et al., 
2006). In brief, anesthetized dogs were used for unrelated experiments involving 
a thoracotomy; the heart was fibrillated and removed to isolate coronary arteries. 
For patch clamp experiments on native vascular smooth muscle cells, arteries 
were obtained from a variety of different species (rat, mouse, dog, and pig). 
Arteries (cerebral, coronary, femoral, and aorta) were taken from animals 
euthanized following unrelated experiments.  
 
Cell culture and transfection 
HEK 293 cells (Stratagene, La Jolla, CA) were grown in Dulbecco’s Modified 
Eagle Medium supplemented with 10% FBS, 100 units/ml penicillin, 100 µg/ml 
streptomycin, and culture flasks were incubated in a 5% CO2 incubator at 37 °C. 
Plasmids encoding hSlo α and hSlo α + β1 were kindly provided by Dr. Jonathan 
Lippiat (Lippiat et al., 2003) and hKV1.5 plasmid was a generous gift from Dr. 
Jeffrey R Martens (McEwen et al., 2007). Cells were transiently transfected with 
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pIRES-hSloα or pIRES-hSloαβ1 and pmaxGFP (AMAXA, Gaithersburg, MD) 
using Lipofectamine LTX with PLUS reagent (Invitrogen, Carlsbad, CA). Cells at 
50-70% confluence in 35 mm dishes were transfected with 0.5-2.5 mg of DNA 
and currents were recorded from GFP positive cells 1-3 days later. Transfected 
cells were selected in media supplemented with 0.5 mg/ml G418 (Invitrogen, 
Carlsbad, CA), 1% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin.  
 
Electrophysiology 
BK channel currents were recorded at room temperature from inside-out and 
whole-cell patches as previously described (Asano et al., 2010). The bath flowed 
~2-3 ml/min into a ~0.2-0.3 ml chamber throughout the recordings. For whole-cell 
recordings, bath solution contained (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 
glucose, 10 HEPES, and 5 Tris; pH 7.4. Pipette solution contained (mM) 140 
KCl, 1 MgCl2, 1 EGTA, 10 HEPES, 1 Mg-ATP, 0.1 Na-GTP and 5 Tris; pH 7.1. 
Inside-out recordings were made in symmetrical (mM) 140 KCl, 1 MgCl2, 1 
EGTA, 10 HEPES, 5 Tris; pH 7.1; pCa 7 (Maxchelator; http://www.stanford.edu/ 
~cpatton/maxc.html). Stock solutions of penitrem A (MP Biomedicals, Solon, OH) 
were prepared in DMSO and diluted for 1:10,000 for experiments. Iberiotoxin 
(AnaSpec, San Jose, CA) was dissolved in water and diluted 1:1000 for 
experiments. 
 
Isometric tension studies 
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Isometric tension was measured from segments of canine left circumflex 
coronary arteries as described previously (Rogers et al., 2006). Arteries were 
denuded of endothelium and the lack of a relaxant response to acetylcholine (10 
µM) in pre-contracted arterial tissue confirmed the functional loss of endothelium. 
For the pinacidil concentration-response experiments, arteries were pre-
contracted with 1 µM U46619, a thromboxane A2 mimetic, and the relaxation 
elicited by cumulative additions of pinacidil in the presence or absence of 1 µM 
penitrem A. For the K+ concentration-response experiments, KCl was added 
cumulatively in the presence or absence of 1 µM penitrem A. 
 
Blood pressure measurements 
Mean arterial pressure was measured as described previously (Ohanyan et al., 
2011). Mice were anesthetized with sevoflurane gas (supplemented with O2) and 
placed on a heating table to maintain body temperature at 37 °C. A polyethylene 
catheter was placed into the jugular vein for bolus administrations of heparin (50 
U/ml) and hexamethonium (5 mg/kg), a ganglionic blocker. A micro-tip transducer 
(Millar Instruments, Houston, TX) was placed in the femoral artery to measure 
mean arterial pressure and heart rate. Data were recorded with a Power Lab 
acquisition system (ADInstruments, Colorado Springs, CO). Phenylephrine (0.5 
µg/kg/min) and penitrem A (100 µg/kg/min) were administered intravenously. 
Stock solutions of penitrem A were dissolved in ethanol and subsequently diluted 





Data are presented as the mean and standard error of n number of samples 
(e.g., number of patches, cells, dogs, or mice as described in the text and figure 
legends). When two values were compared, paired or unpaired t-tests were used 
as appropriate. When three values were compared, one-way analysis of variance 
(ANOVA) was used. Current-voltage relationships and concentration-response 
curves were analyzed by two-way ANOVA. Bonferroni post hoc tests followed 
ANOVA to determine differences. In all tests, p<0.05 was considered significant. 
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Results 
Penitrem A inhibits BK channels in a concentration-dependent manner: 
influence of the β1 subunit. 
Whole-cell patch clamp techniques were used to determine the effect of penitrem 
A on cloned BK channels (α or α + β1) expressed in HEK 293 cells. Currents at 
+100 mV were recorded under control conditions (in the presence of vehicle; 
0.01% DMSO) and after addition of penitrem A (Fig. 1A & B). In cells expressing 
BK channels composed solely of α subunits, inhibition of current by 100 nM 
penitrem A was 93 ± 1% (n = 13 cells; Fig. 1A&C). In contrast, when BK 
channels contained the regulatory β1 subunit, block by 100 nM penitrem A was 
only 41 ± 9% (n = 9 cells; Fig. 1B&C). Over several log orders of penitrem A 
concentrations, BK channels composed of α subunits alone were more sensitive 
to block than BK channels containing the β1 subunit (Fig. 1C). The half-maximal 
inhibitory concentration (IC50) of penitrem A for BK α was 6.4 nM (log IC50 = -8.20 
± 0.08; n = 7-16 cells). The IC50 of penitrem A on BK α + β1 subunits was 64.4 
nM (log IC50 = -7.19 ± 0.07; n = 4-15 cells; p<0.05). Hill slopes were equivalent (-
0.91 ± 0.12 vs. -1.07 ± 0.15). In addition to reduced sensitivity, the time course of 
channel block by penitrem A was slowed by the β1 subunit (Fig. 1D & E). The 
inhibitory effect of penitrem A on BK channel current was, for all practical 
purposes, irreversible (Fig. 2). When current in cells expressing BK channels 
composed of α + β1 subunits was inhibited by 1 µM penitrem A, 10 or more min 
of washing was insufficient time for appreciable reversal (Fig. 2A). After 2 min of 
penitrem A (1 µM) exposure, current was inhibited 91 ± 2% (n = 5; Fig. 2B). Cells 
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were studied in a ~0.2-0.3 ml chamber that was perfused at ~2-3 ml/min; 
however, washing cells for 14 min with penitrem A-free bath solution did not 
allow BK current to recover (Fig. 2B; current at the 20 min mark was only 6 ± 2% 
of the control level). Similar irreversibility was observed in native smooth muscle 
cells (e.g., rat aorta) with lower concentrations of penitrem A (e.g., 50 nM; Fig. 
2C & D). 
 
Penitrem A, but not iberiotoxin, inhibits BK channels in inside-out patches. 
Iberiotoxin blocks BK channels by “plugging” the pore from the extracellular side 
(Giangiacomo et al., 1992); therefore, one cannot use bath application of 
iberiotoxin to block BK channels in cell-attached or inside-out patches. A 
common strategy to overcome this limitation is to backfill patch pipettes with 
iberiotoxin, thus allowing some time for control measurements while iberiotoxin 
diffuses to the tip. A membrane-permeable BK channel antagonist could 
strengthen experimental design and allow more time for control measurements 
and/or interventions prior to BK channel block. We compared the effects of 
iberiotoxin (100 nM) and penitrem A (100 nM) on BK channels in cell-attached 
and inside-out patches (Fig. 3). As expected, bath application of iberiotoxin to 
inside-out patches of had no inhibitory effect on BK channel activity. In contrast, 
bath application of penitrem A inhibited BK channel activity in inside-out patches. 
Mean NPo of BK α alone under control conditions, with iberiotoxin, and with 
penitrem A was 0.077 ± 0.040, 0.103 ± 0.076, and 0.002 ± 0.001, respectively. 
(p<0.05 for penitrem A, n = 7-10). Similarly, mean NPo of BK α + β1 under control 
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conditions, with iberiotoxin, and with penitrem A was 0.401 ± 0.158, 0.564 ± 
0.235, 0.015 ± 0.014 (p<0.05 for penitrem A, n = 7-13). Like the whole-cell 
recordings, BK channel block by penitrem A was not readily reversible with 
extensive washing. In contrast to the whole-cell recordings where 100 nM 
penitrem A inhibited BK α + β1 by less than half (Fig. 1), 100 nM penitrem A 
inhibited BK α + β1 in inside-out patches by 97 ± 1%. This increased inhibitory 
effect at the cytoplasmic face was also noted in the original description of 
penitrem A (Knaus et al., 1994). 
 
Specificity of penitrem A: block of BK, but not KV or KATP channels. 
The effect of penitrem A to inhibit K+ current in coronary artery smooth muscle 
cells is equivalent to iberiotoxin (Fig. 4). In coronary myocytes, penitrem A (300 
nM) inhibited BK current significantly, and the remaining current appeared to be 
mediated by KV channels (Fig. 4A & B). After penitrem A treatment, iberiotoxin 
(100 nM) had no further inhibitory effect on current at +100 mV (Fig. 4C); when 
iberiotoxin was added first, penitrem A had no further inhibitory effect (Fig. 4D). It 
is unclear what KV channel type(s) mediate the delayed rectifier K+ currents in 
smooth muscle, but KV1.5 has been suggested as a component (Chen et al., 
2006; Dick et al., 2008). Thus, we determined whether penitrem A could inhibit 
cloned KV1.5 channels (Fig. 5A & B). Whole-cell recordings of KV1.5 current were 
made from HEK 293 cells transfected with hKV1.5 plasmid (McEwen et al., 2007). 
Penitrem A (1 µM) had no effect on KV1.5 channels; current at +60 mV in the 
presence of penitrem A was 105 ± 6% of control (n = 5). We tested the effect of 
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penitrem A on total outward K+ current in a variety of other native vascular 
smooth muscle cells (Supplemental figure). In each species and tissue, penitrem 
A (1 mM) inhibited BK current (i.e., strongly outwardly rectifying current at 
positive potentials) and appeared to have little or no effect on native delayed 
rectifier channels. 
KATP channels are another major type of K+ channel in coronary smooth 
muscle (Dart & Standen, 1995); therefore, we determined whether penitrem A 
could inhibit KATP channels. Dog coronary arteries were contracted with U44619 
(a thromboxane A2 mimetic; 1 µM) and relaxed with pinacidil, a KATP channel 
opener. These experiments were performed in the presence or absence of 
penitrem A (1 µM). Pinacidil-induced relaxation was unaffected by penitrem A 
(Fig. 5C & D; arteries from n = 3 dogs; maximum relaxation 91 ± 5 vs. 94 ± 2% 
and log IC50 = -5.94 ± 0.11 vs. -5.85 ± 0.07). We performed patch clamp 
experiments to measure directly the effects penitrem A on pinacidil-induced KATP 
current activation. Whole-cell current in mouse aortic myocytes (n = 6) was 
measured at -50 mV in symmetrical 140 mM K+. Pinacidil (10 µM) activated 165 
± 49 pA of inward current. Penitrem A (1 µM) had no effect on pinacidil-activated 
current (87 ± 6% of control); however, glibenclamide (10 µM) inhibited pinacidil-
activated current 80 ± 7% (p < 0.05). 
 
Penitrem A augments smooth muscle contractility in vitro and in vivo. 
To test penitrem A as a functional inhibitor of smooth muscle BK channels in 
vitro, K+ concentration-response curves were constructed for coronary arteries in 
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the presence or absence of 1 µM penitrem A. Inhibition of BK channels produced 
a leftward shift in the K+ concentration-response curve (Fig. 6). Contractions with 
20, 30, and 40 mM K+ were increased 79 ± 12, 26 ± 5 and 12 ± 4% by blocking 
BK channels with 1 µM penitrem A (p<0.05; arteries from n = 8 dogs). To test 
penitrem A as a functional inhibitor of smooth muscle BK channels in vivo, blood 
pressure responses to phenylephrine, an a1 adrenergic agonist, were measured 
in anesthetized mice. Hexamethonium (5 mg/kg i.v.), a nicotinic receptor 
antagonist, was used to eliminate reflex responses to blood pressure changes. 
Phenylephrine (0.5 µg/kg/min i.v.) increased blood pressure to a steady state 
level and then addition of penitrem A (100 µg/kg/min) increased blood pressure 
further (Fig. 7A). In 5 mice (Fig. 7B), phenylephrine increased mean blood 
pressure from 57 ± 2 to 77 ± 1 mmHg (p<0.05), while the addition of penitrem A 





The objective of this study was to better characterize penitrem A as an 
inhibitor of BK channels (Knaus et al., 1994). Penitrem A has been used 
previously as inhibitor of BK channels in smooth muscle (Cotton et al., 1997; 
Borbouse et al., 2009; Asano et al., 2010). Importantly, however, employment of 
penitrem A as a BK channel antagonist has been without a complete 
understanding of its pharmacological properties. For example, the IC50 was not 
known and it was unclear whether BK channel subunit composition might affect 
the block. We show that penitrem A inhibits BK α and α+ β1 with IC50 values of 
6.4 and 64.4 nM (Fig. 1) Additionally, the use of penitrem A to study BK channels 
has been, until recently (Borbouse et al., 2009; Borbouse et al., 2010a; Borbouse 
et al., 2010b), limited to in vitro studies, particularly patch clamp experiments. 
Thus, we further investigated penitrem A as a BK channel inhibitor to assess 
vascular function in vitro and in in vivo. We show that penitrem A enhances 
smooth muscle contraction in vitro (Fig. 6) and increases total peripheral 
resistance in vivo (Fig. 7). Information regarding the specificity of penitrem A 
against other ion channels was limited to Ca2+-activated Cl- channels (Sones et 
al., 2009), where it had very little effect. Here we demonstrate no effect of 
penitrem A on native delayed rectifier, cloned KV1.5, or KATP channels (Figs. 4 
and 5 and Supplement). Iberiotoxin and penitrem A are roughly equivalent in 
potency and efficacy (Fig. 4 and Table 1), but penitrem A is less than 0.1% of the 
cost on a per mole basis. We conclude that penitrem A is comparable to 
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iberiotoxin in potency, efficacy, and selectivity and, further, that penitrem A can 
be a more useful and economical alternative. 
BK channel subunit knockout mice have become a popular experimental 
model for studying smooth muscle reactivity and a great deal of important 
information has been gleaned; however, this approach comes with certain 
limitations. For example, deletion of K+ channel genes elicits phenotypic 
compensations that may compromise interpretation (Nerbonne et al., 2008). 
Such changes may explain variable observations regarding blood pressure in BK 
channel subunit knockout mice. For instance, BK β1 subunit knockout mice were 
originally reported as hypertensive (Brenner et al., 2000; Pluger et al., 2000), but 
a recent study contradicted this (Xu et al., 2011). The earlier studies included 
acute measurements of blood pressure in conscious mice with arterial catheters, 
whereas the later study used radiotelemetry to monitor blood pressure 
continuously for 1 wk. Both approaches are valid and it remains unknown 
whether differences in the method of blood pressure measurement or the 
response to stress could explain the discrepancies; however, compensatory 
changes in other K+ channels or physiological mechanisms might be responsible 
for observations of normal blood pressure in BK β1 subunit knockout mice. An 
alternative explanation is that BK channels may play a minimal role in regulating 
total peripheral resistance. Thus, the power of traditional pharmacological 
approaches to inhibit BK channels in order to elucidate a mechanism of action 
should not be underestimated, as we (Borbouse et al., 2009; Borbouse et al., 
2010a; Borbouse et al., 2010b) and others (Node et al., 1997) have previously 
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demonstrated little, if any role, for BK channels in regulating coronary vascular 
tone using penitrem A, charybdotoxin, or iberiotoxin. No comparable studies of 
organ blood flow are available for BK channel subunit knockout mice; this is likely 
due to the difficulty of instrumenting small animals. Studies of BK channels in 
regional and systemic hemodynamics might be made more readily in larger 
animals by employing suitable pharmacological tools such as paxilline, lolitrem B, 
and penitrem A (Table 1). It must be kept in mind, however, that penitrem A was 
first reported in the literature due to its tremorgenic effects; therefore, its use in 
vivo may best be limited to anesthetized animals because of potential 
neurological side effects and convulsant properties. 
Some characteristics of BK channel block by penitrem A are compared to 
those of other BK channel antagonists in Table 1. It is important to note that while 
experimental details such as patch potential and free Ca2+ are not identical, a 
fairly consistent picture emerges. Moreover, our data were generated using the 
plasmids of Lippiat and colleagues (2003), allowing a relatively direct 
comparison. Penitrem A appears to be one-half to one log order more potent 
than iberiotoxin, while the presence of β1 subunits reduces sensitivity to either 
agent by a factor of 10. All of the pharmacological tools characterized in Table 1 
block BK channels with similar efficacy (>95%). Penitrem A can inhibit BK 
channels whether it is applied from intracellular or extracellular side of the 
membrane; this property is shared by paxilline and lolitrem B, but not iberiotoxin. 
We found that β1 subunits decrease BK channel sensitivity to penitrem A. This is 
different from paxilline or lolitrem B, which block BK α, α + β1, and α + β4 with 
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similar potency (Imlach et al., 2008). Specificity for BK channels is another issue 
surrounding the available antagonists. Paxilline has been reported as an inhibitor 
of Ca2+-activated Cl- channels, whereas penitrem A and iberiotoxin have much 
less effect (Sones et al., 2009). In the original report (Knaus et al., 1994), it was 
mentioned that paxilline weakly blocks delayed rectifier K+ channels in mouse 
pancreatic β cells, but we show here that penitrem A has no effect on native 
delayed rectifier, cloned KV1.5, or KATP channels (Fig. 4 and 5). More studies will 
be necessary to determine possible off-target interactions of penitrem A; these, if 
any, may be expected to arise from introducing penitrem A into complex systems 
such as isolated organ or whole animal experiments. 
Importantly, however, the effects of penitrem A we observed in isolated 
arteries in vitro and on blood pressure in vivo were relatively straightforward and 
can be interpreted as specific effects on BK channels (Figs. 6 and 7). For 
example, in Fig. 6, the effect of penitrem A to increase smooth muscle 
contraction is consistent with what has been reported previously for iberiotoxin 
(Brayden & Nelson, 1992; Bratz et al., 2005). We assessed the effect of penitrem 
A on smooth muscle tone in vivo by measuring blood pressure in anesthetized 
mice (Fig. 7). C57BL/6 mice are a common background for engineered mice; 
therefore, these data may be a reference for those interested in using penitrem A 
in knockout or transgenic mice. A recent study demonstrated that lolitrem B had 
no effect on blood pressure, but decreased heart, in mice (Imlach et al., 2010). 
Our first impression was that these results could be explained by a reflex 
adjustment of heart rate, and thus cardiac output, and ultimately blood pressure 
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in response to an increase in total peripheral resistance. However, Imlach et al. 
went on to demonstrate an inhibitory effect of lolitrem B on heart rate in 
Langendorff-perfused hearts, where neural input is removed. The mechanism(s) 
by which lolitrem B reduces heart rate are unknown; however, it is important to 
note that they are not shared by penitrem A. We used hexamethonium to block 
autonomic responses and heart rate was unchanged during penitrem A-induced 
increases blood pressure (Fig. 7). 
We demonstrated the efficacy and selectivity of penitrem A on BK channel 
function in vitro and in vivo; however, our study has several limitations that need 
to be addressed. First, penitrem A is well known to cause muscle tremor, thus, 
the use of penitrem A to study the role of vascular BK channels might best be 
limited to anesthetized animals for in vivo experiments. Second, in addition to 
vascular smooth muscle BK channels, systemic penitrem A administration will 
inhibit BK channels in other cells and tissues that might affect the regulation of 
vascular tone and blood pressure. For instance, a recent study indicated that BK 
channels in astrocytes are key regulators of neurovascular coupling (Girouard et 
al., 2010). Additionally, BK channels in endothelium may regulate membrane 
potential, Ca2+ influx, and the production of relaxing factors (Sandow & Grayson, 
2009). Since BK channel expression is ubiquitous, in vivo experiments with 
penitrem A will require careful design and interpretation.  
In conclusion, we have further characterized penitrem A as an inhibitor of 
BK channels, particularly BK a + b1 channels that are generally found in smooth 
muscle. This information could be put to important use determining the roles of 
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BK channels in vascular function and serve as a complement to studies 
performed in BK channel subunit knockout mice. We demonstrate that penitrem 
A is a useful and economical alternative for studying the role of BK channels in 
vitro and in vivo. That is, we show that that the use of penitrem A is not limited to 
patch clamp experiments, rather this agent is practical for tissue, organ, and 
whole animal studies.  
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Legends for figures 
Fig. 1 Presence of the β1 subunit decreases the sensitivity of BK channels 
to penitrem A. Representative traces of BK current at +100 mV in HEK 293 cells 
transfected with hSlo α (Panel A) or hSlo α + β1 (Panel B). Whole-cell current 
was measured before (control) and after addition of penitrem A (100 nM). Group 
data (Panel C; n = 4-16 cells at each concentration) show the effect of BK 
channel subunit composition on sensitivity to block by penitrem A. Asterisks 
indicate p<0.05 between the two groups as determined by two-way ANOVA. 
Group data (n = 3-9) show time- and concentration-dependent block of BK a 
(Panel D) and α + β1 (Panel E) by penitrem A. Note that, compared to a, a 10x 
higher concentration of penitrem A is required to achieve a similar time-
dependent block in α + β1. 
 
Fig. 2 Irreversible block of BK channels by penitrem A. Current traces are 
shown from a representative HEK 293 cell expressing BK channels composed of 
α + β1 subunits (Panel A). The voltage template used is shown below the 
current. Penitrem A (1 µM) abolished current within 1-2 min; however, 10 min of 
washing in penitrem A-free bath solution was not sufficient time for current to 
recover appreciably. (Panel B) Group data (n = 5 cells) illustrate the practical 
irreversibility of a 2 min exposure to penitrem A; BK current at +100 mV is plotted 
vs. time. Current traces are shown from a representative rat aortic smooth 
muscle cell (Panels C and D). The voltage template was same as above. 
Penitrem A (50 nM) reduced native BK current and was practically irreversible. 
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Fig. 3 Penitrem A blocks BK channels in inside-out and cell-attached 
patches. Recordings of channel activity from representative inside-out patches 
are shown for BK α (Panel A) or α + β1 (Panel B). Patch potential was +40 mV 
and solutions were symmetrical 140 mM K+ with 100 nM free Ca2+. Channel 
activity was recorded under control conditions and with bath application of 
iberiotoxin (100 nM) or penitrem A (100 nM). (Panel C) Penitrem A blocks BK 
channel (α + β1) activity in a cell-attached patch. Channel activity was recorded 
under control conditions and with bath application of penitrem A (100 nM). (Panel 
D) Group data (n = 23 patches) show that the exposure of the cytosolic side of 
inside-out patches to penitrem A, but not iberiotoxin, inhibits BK channel activity. 
Asterisk indicates p<0.05 vs. control by one-way ANOVA. 
 
Fig. 4 Iberiotoxin and penitrem A block the same current in canine coronary 
smooth muscle cells. (Panel A) Families of current traces from a representative 
dog coronary artery smooth muscle cell are shown under control conditions, with 
penitrem A (300 nM), and with iberiotoxin (100 nM). These experiments were 
performed with a bath solution containing 0.01% bovine serum albumin to limit 
nonspecific binding of iberiotoxin to plastic. (Panel B) The I-V relationships from 
traces in A are shown. Penitrem A and iberiotoxin block the same current (inset). 
(Panel C) Group data (cells from n = 5 dogs) demonstrate that penitrem A blocks 
iberiotoxin-sensitive current; current at +100 mV is shown. (Panel D) Similarly, 
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iberiotoxin blocks penitrem A-sensitive current at +100 mV. Asterisks indicate 
p<0.05 vs. control by one-way ANOVA. 
 
Fig. 5 Penitrem A has no effect on KV1.5 or KATP channels. (Panel A) Whole-
cell recordings were made from HEK 293 cells transfected with hKV1.5. 
Representative KV1.5 currents in the absence or presence of 1 µM penitrem A. 
(Panel B) Group data (n = 5 cells) show that penitrem A (1 µM) has no effect on 
KV1.5 current. (Panel C) Representative isometric tension recordings show that 
penitrem A (1 µM) does not inhibit pinacidil-induced relaxation. (Panel D) Group 
data (arteries from n = 3 dogs) show that penitrem A (1 µM) has no effect on KATP 
channels. Arteries were contracted with 1 µM U46619 and relaxed with 
cumulative additions of pinacidil. 
 
Fig. 6. Penitrem A selectively inhibits BK channel to alter vascular 
contraction from in vitro vascular functional experiments. 
Panel A) Representative traces for KCl induced contraction with/without penitrem 
A are shown. (Panel B) Group data showed a leftward shift in contraction 
response with penitrem A. Asterisks (*) indicate significant difference (p< 0.05) 
from control by two-way ANOVA. 
 
Fig. 7 Block of BK channels by penitrem A augments phenylephrine-
induced blood pressure responses in mice. (Panel A) Mean arterial pressure 
and heart rate are shown for a representative mouse. The mouse received 
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phenylephrine (0.5 µg/kg/min i.v.), which increased pressure. There was no 
reflex change in heart rate, as the ganglionic blocker hexamethonium (5 mg/kg 
i.v.) was injected prior to the experiment. Penitrem A (100 µg/kg/min i.v.) was 
added and increased pressure further. (Panel B) Group data (n = 5 mice) 
illustrate effect of penitrem A to augment phenylephrine-induced pressor 
responses. Asterisk and dagger indicate significant difference (p<0.05) from 
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We determined the effect of penitrem A on K+ currents in a variety of native 
vascular smooth muscle cells. The point of these experiments is to demonstrate 
that penitrem A (1 µM) inhibits the same type of strongly outwardly rectifying 
current without effect on native delayed rectifiers. Panels A-E show currents in 
smooth muscle cells isolated from rat middle cerebral artery (n = 3), rat femoral 
artery (n = 3), mouse aorta (n = 3), pig coronary artery (n = 5), and dog coronary 
artery (n = 7). The voltage template (shown in A) was the same for all 
experiments. Solutions for whole-cell currents are described in the Methods. 
Panel F contains data showing that penitrem A 1 µM inhibits the a subunit cloned 
from cow (courtesy of Dr. Michael Davis, University of Missouri) and expressed in 






Figure 2 8 Supplemental Figure1 Penitrem A on K+ currents in a variety of 







Figure 2 9 Supplemental Figure2 Penitrem A on K+ currents in a variety of 
vascular smooth muscle cells 
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Abstract 
Background and purpose: Bisphenol A (BPA) is used to manufacture plastics, 
including food containers into which it leaches. High levels of exposure to this 
estrogenic endocrine disruptor are associated with diabetes and heart disease. 
Estrogen and estrogen receptor modulators increase the activity of large 
conductance Ca2+/voltage-sensitive K+ (Maxi-K) channels, but the effects of BPA 
on Maxi-K channels are unknown. We tested the hypothesis that BPA activates 
Maxi-K channels through a mechanism that depends upon the regulatory β1 
subunit.  
Experimental approach: Patch clamp recordings of Maxi-K channels were made 
in human and canine coronary smooth muscle cells as well as in AD-293 cells 
expressing pore-forming α or α plus β1 subunits.  
Key results: BPA (10 µM) activated an outward current in smooth muscle cells 
that was inhibited by penitrem A (1 µM), a Maxi-K blocker. BPA increased Maxi-K 
activity in inside-out patches from coronary smooth muscle, but had no effect on 
single channel conductance. In AD-293 cells with Maxi-K channels composed of 
α subunits alone, 10 µM BPA did not affect channel activity. When channels in 
AD-293 cells contained β1 subunits, 10 µM BPA increased channel activity. 
Effects of BPA were rapid (<1 min) and reversible. A higher concentration of BPA 
(100 µM) increased Maxi-K current independent of the β1 subunit.  
Conclusions and implications: These data indicate BPA increases the activity of 




Although there is no clear consensus on detrimental health effects of BPA, 
evidence suggests it possesses endocrine disrupting activity. BPA may affect 
fetal and neonatal development (Vandenberg et al., 2007), reproductive function 
(Savabieasfahani et al., 2006), metabolism (Hugo et al., 2008), and 
carcinogenesis (Wetherill et al., 2002; Wetherill et al., 2005). A recent study 
demonstrated an association between BPA levels and adverse cardiovascular 
diagnoses (Lang et al., 2008). Environmental exposure through polycarbonate 
plastic bottles, epoxy linings of canned foods, and dental sealants makes BPA a 
potential public health hazard. 
BPA interacts with nuclear estrogen receptors, although much less 
potently than 17β-estradiol (Krishnan et al., 1993; Kuiper et al., 1997). BPA also 
exerts nongenomic effects, independent of nuclear estrogen receptors. For 
example, BPA rapidly disrupts intracellular Ca2+ homeostasis in a variety of cells 
(Nadal et al., 2000; Alonso-Magdalena et al., 2005; Walsh et al., 2005). These 
data suggest that BPA influences the activity of cellular transport mechanisms, 
perhaps including ion channels. Importantly, however, there are no data available 
regarding effects of BPA on the function of an ion channel per se. Maxi-K 
channels offer themselves as an excellent model to test for interactions with 
BPA, as they are estrogen-sensitive (Valverde et al., 1999). 
Maxi-K channels, identified as KCa1.1 in the Guide to Receptors and 
Channels (Alexander et al., 2008), are formed by 4 pore-forming α subunits 
encoded by KCNMA1 (Butler et al., 1993); when β1 subunits are present, 
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sensitivity to estrogenic substances is conferred (Valverde et al., 1999; Dick et 
al., 2001; Dick & Sanders, 2001; Dick et al., 2002; Duncan, 2005; Coiret et al., 
2007). The majority of Maxi-K channels in vascular smooth muscle contain this 
regulatory β1 subunit, encoded by KCNMB1 (Tanaka et al., 1997), which 
increases Ca2+- and voltage-sensitivity (McManus et al., 1995; Meera et al., 
1996). Maxi-K channels (Nelson et al., 1995) and the β1 subunit (Brenner et al., 
2000) play key roles in regulating smooth muscle excitability. The present study 
was designed to determine whether BPA activates Maxi-K channels and to 
ascertain the role of the β1 subunit. We hypothesized that BPA would activate 
Maxi-K channels through a mechanism that depends upon the β1 subunit. To 
test this hypothesis, Maxi-K channel currents were analyzed in smooth muscle 
cells and in AD-293 cells expressing α or α + β1 subunits. 
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Methods 
Smooth muscle cells. Three coronary artery smooth muscle preparations 
were used; these include cells: a) freshly isolated from the canine left anterior 
descending (LAD) artery; b) cultured from the canine LAD; and c) cultured from 
human hearts. Canine LAD arteries were collected from dogs euthanized under 
surgical anesthesia for unrelated experiments. Protocols were approved and 
followed guidelines set forth in the Guide for the Care and Use of Laboratory 
Animals (National Academy Press, 1996). LAD segments were incubated for 30 
min at 37 °C in 20 units ml-1 papain in low Ca2+ HEPES buffer containing (mM) 
135 NaCl, 5 KCl, 0.36 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 
7.4. After washing, tissue was incubated for another 30 min at 37 °C in low Ca2+ 
HEPES buffer containing (mg ml-1) 2 type II collagenase and 1 hyaluronidase. 
The solution was gently agitated with a fire-polished Pasteur pipette to disperse 
single cells. This suspension was filtered through 100 µm nylon mesh and 
centrifuged at 600 g for 5 min. For patch clamp recordings, the pellet was 
resuspended with low Ca2+ HEPES buffer and kept at 4 °C. Patch-clamp 
recordings were performed within 8 h of cell dispersion. For primary cell culture, 
solutions mentioned above also contained 100 units ml-1 penicillin and 100 mg 
ml-1 streptomycin and the pellet was resuspended in Medium 231 with smooth 
muscle growth supplement (Invitrogen). Cells were plated on 1% gelatin-coated 
dishes and incubated in a 5% CO2 incubator at 37 °C. Media was replaced once 
or twice as cells grew to confluence; after subculturing, the medium was changed 
every 2-3 days. To induce differentiation in confluent cultures, growth medium 
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was switched to Medium 231 containing smooth muscle differentiation 
supplement (Invitrogen), which was replaced every 2-3 days. Human coronary 
artery smooth muscle cells (Genlantis) were cultured in Medium 231 with growth 
and differentiation supplements, the latter added at ∼80% confluence. 
Transient transfection. AD-293 cells (Stratagene) were grown in DMEM 
supplemented with 10% FBS, 100 units ml-1 penicillin, and 100 mg ml-1 
streptomycin. Antibiotic-free media was added 1 h prior to transfection. Plasmids 
encoding bovine KCNMA1 (ENSG00000156113) and KCNMB1 
(ENSG00000145936) were kindly provided by Dr. Michael J. Davis (University of 
Missouri; (Wu et al., 2008)). A plasmid encoding GFP, pmaxGFP, was purchased 
from AMAXA. Cells grown to 50-70% confluence were cotransfected with 
plasmids containing GFP and KCNMA1 with or without KCNMB1 using 
Lipofectamine LTX with PLUS reagent (Invitrogen). Transfection with GFP 
plasmid only was used as a negative control. The optimal molar ratios of 
KCNMA1 to KCNMB1 were determined to be >1:3. After incubation with DNA-
lipid complexes in opti-MEM for 6 h, the medium was changed to DMEM 
supplemented with FBS and antibiotic. Current recordings from GFP-positive 
cells were performed 1-2 days after transfection.  
Electrophysiology. Freshly isolated cells were placed directly in a 
recording chamber on an inverted microscope, while cultured cells were plated 
on cover glass that was transferred to the recording chamber. The recording 
chamber had a volume of 0.2-0.3 ml and solutions were fed by gravity at a rate of 
2-3 ml min-1. BPA (Sigma-Aldrich; product number 133027) and penitrem A (MP 
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Biomedicals) were dissolved in DMSO and diluted 1:1000 or 1:10,000 for 
experiments. For whole-cell recordings, cells were suffused with a solution 
containing (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and 
5 Tris; pH 7.4. Pipette solution contained (mM) 140 KCl, 1 MgCl2, 1 EGTA, 10 
HEPES, and 5 Tris; pH 7.1. The Ca2+ concentration of the pipette solution was 
brought to 100 nM by adding 281 µM CaCl2 (http://www.stanford.edu/ 
~cpatton/maxc.html). GΩ seals were made with heat-polished borosilicate 
pipettes (BF150-86; Sutter Instruments) that had tip resistances of 3-5 MΩ. The 
cell was ruptured with suction and membrane capacitance determined from the 
capacity transient (pClamp 9; Axon Instruments). Series resistance and 
capacitance were compensated as much as possible using the amplifier circuitry 
(PC-505B; Warner Instruments). In whole-cell records, mean current during the 
last 80 ms of the test pulse was measured for analysis. For single channel 
recordings, cells were suffused with the 140 mM K+ solution described above and 
pipettes had tip resistances of 5-10 MΩ. After forming GΩ seals, patches were 
excised for inside-out recordings in symmetrical 140 mM K+. Channel 
conductance was determined from peak-to-peak differences in all-points 
amplitude histograms; NPo was calculated by dividing the mean current in a trace 
by the single channel amplitude. Currents were low pass filtered at 1 kHz and 
digitized at 5 kHz. 
RT-PCR. Total RNA was extracted using PureLink RNA Mini kit and 
PureLink DNase (Invitrogen). One microgram of template was reverse 
transcribed with Oligo(dT)20 primers using the SuperScript First-Strand Synthesis 
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System (Invitrogen). PCR primers were designed against KCNMA1 
(NM_001014797; 5’-GAGGATGCCTCGAATATCA-3’ and 5’-AGCTCG 
GGATGTTTAGCAGA-3’; product size 119 bp) and KCNMB1 (NM_004137; 5’-
GCCGGG AAGACTAAATGATC-3’ and 5’-TGGGAT GTAGGAGCACTG-3’; 
product size 357 bp). PCR amplification was performed in 50 µl reactions 
containing 1x PCR buffer, 0.2 mM each dNTP, 1.5 mM MgCl2, 0.4 µM each 
primer, 1 µl template cDNA, and 2 units Platinum Taq DNA polymerase 
(Invitrogen). The protocol included: denature at 94 °C for 2 min, 40 cycles of 94 
°C for 15 s, 55 °C for 30 s, and 70 °C for 1 min; the reaction was terminated at 4 
°C. As a positive control, human brain cDNA (Ambion) was used. PCR products 
were separated by electrophoresis on 2% agarose with ethidium bromide and 
images captured using a GeneFlash unit (Syngene). 
Statistics. Data are presented as the mean and standard error of n 
number of cells or membrane patches. When two values were compared, a 
paired t-test was used. When more than two values were compared, one-way 
ANOVA was used. Current-voltage relationships were analyzed by two-way 
repeated measures ANOVA. Bonferroni post hoc tests followed ANOVA to 




The patch clamp technique was used to measure K+ current in coronary 
smooth muscle cells and determine the effect of BPA on Maxi-K current using 
penitrem A, a potent and selective inhibitor of Maxi-K channels (Knaus et al., 
1994). Whole-cell recording revealed prominent Maxi-K current in smooth muscle 
cells cultured from the canine LAD coronary artery (Fig. 1A, left). Time-
dependent current increased sharply at potentials positive to +40 mV and was 
“noisy”, indicating channels with a large unitary conductance were responsible. 
Current density at +100 mV was 35 ± 12 pA pF-1 (n = 5). Whole-cell current 
increased with the application of 10 µM BPA (Fig. 1A, middle; current density at 
+100 mV was 64 ± 24 pA pF-1, p < 0.05). The effect of BPA was not voltage-
dependent. Penitrem A (1 µM) blocked nearly all of the whole-cell current in 
smooth muscle cells cultured from the canine LAD coronary artery (Fig. 1A, right; 
current density at +100 mV was 3 ± 2 pA pF-1, p < 0.05). In separate experiments 
(n = 4) when 1 µM penitrem A was added first, whole-cell current was reduced 
and could not be increased by 10 µM BPA (Fig. 1B; current density at +100 mV 
was 33 ± 10, 6 ± 3, and 4 ± 2 pA pF-1, for control, with penitrem A, and penitrem 
A plus BPA, respectively; p < 0.05). The voltage template used to elicit currents 
is shown in Fig. 1C. Group data for both experiments in cultured canine coronary 
smooth muscle cells are shown in Figs. 1D and E. Cultured canine coronary 
smooth muscle cells were derived from 3 different dogs and a characterization of 
the smooth muscle phenotype of these cells is available in the Supplement. 
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Excised patch recordings were used to determine the effect of BPA on 
Maxi-K channel NPo in smooth muscle cells freshly isolated from the canine LAD 
coronary artery. Inside-out recordings were made in symmetrical 140 mM K+ at a 
patch potential of +80 mV with free Ca2+ buffered to 100 nM. BPA (10 µM) 
increased Maxi-K channel NPo 742 ± 302% (n = 10 cells from 4 dogs; p < 0.05; 
Fig. 2A & B). Single channel conductance was not affected by 10 µM BPA (100 ± 
3% of control; Fig. 2C). 
To determine the role of the β1 subunit in responses to 10 µM BPA, 
whole-cell recordings were performed on AD-293 cells transfected with GFP and 
α or α + β1 subunits. Cells transfected with GFP only had very small outward 
currents (Fig. 3A; current at +100 mV was 0.04 ± 0.01 nA; n = 3). Cells 
transfected with Maxi-K α subunits demonstrated large outward currents with fast 
activation and little or no inactivation (Fig. 3B). The current and time constant of 
activation at +100 mV were 5.4 ± 1.0 nA and 1.0 ± 0.3 ms, respectively (n = 11). 
Cells transfected with both Maxi-K α and β1 subunits possessed large outward 
currents with slower activation and demonstrated little or no inactivation (Fig. 
3C). Current and time constant of activation at +100 mV were 5.0 ± 1.0 nA and 
13 ± 7 ms, respectively (n = 7). In cells with Maxi-K channels composed of α 
subunits alone, 10 µM BPA did not substantially increase current (Fig. 3D; 
current at +100 mV was 101 ± 13% of control). When Maxi-K channels were 
composed of α and β1 subunits, 10 µM BPA increased current by 53 ± 12% (Fig. 
3E). Penitrem A (1 µM) blocked virtually all Maxi-K current, regardless of whether 
channels were composed of α or α + β1 subunits (93 ± 4 and 93 ± 2% inhibition, 
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respectively). Group data illustrating the effects of BPA and penitrem A on Maxi-
K channels composed of α or α + β1 subunits are shown in Fig. 3F & G. 
Inside-out patch recordings were made to determine the effect of 10 µM 
BPA on Maxi-K channels composed of α or α + β1 subunits in AD-293 cells. NPo 
and single channel conductance were determined at a patch potential of +40 mV 
in solutions containing 140 mM K+ and 100 nM free Ca2+. BPA had no significant 
effect on NPo or single channel conductance in Maxi-K channels composed of α 
subunits alone (Fig. 4A & C). NPo was 123 ± 20% of control in the presence of 10 
µM BPA (Table 1; n = 6; p = N.S.). In contrast, in Maxi-K channels containing the 
β1 subunit, 10 µM BPA increased NPo (Fig. 4B & D). BPA increased the NPo of 
Maxi-K channels containing the β1 subunit 204 ± 41% (Table 1; n = 6, p < 0.05). 
BPA had no effect on conductance in channels composed of α or α + β1 subunits 
(99 ± 1 and 103 ± 2% of control, respectively). 
Experiments were performed on α and α + β1 Maxi-K channels in AD-293 
cells to determine whether the effects of BPA were concentration-dependent and 
reversible. The response to BPA depended upon the molecular composition of 
Maxi-K channels (Fig. 5A). When Maxi-K channels contained the β1 subunit, 1, 
10, and 100 µM BPA increased current. This was sharply different from the 
response of Maxi-K channels composed of α subunits alone, where neither 1 nor 
10 µM BPA significantly increased current. Surprisingly, however, at a 
concentration of 100 µM, BPA increased significantly the current in AD-293 cells 
expressing only the α subunit. The effect of BPA to increase whole-cell Maxi-K 
current was rapid and readily reversible (Fig. 5B). Current through channels 
 92 
composed of α + β1 subunits increased dramatically during exposure to 10 µM 
BPA (from 4.5 ± 0.4 to 5.6 ± 0.6 nA; p < 0.05, n = 4). In cells expressing α 
subunits only, 10 µM BPA modestly increased current from 4.4 ± 0.3 to 4.6 ± 0.1 
nA (n = 4). There was no difference in the time course for the onset of BPA effect 
between cells expressing α or α + β1 subunits (time constants of 2.0 ± 0.1 vs. 2.1 
± 0.1 min) (Fig. 5C). Washing the cells with BPA-free solution rapidly returned 
current towards baseline. 
Whole-cell patch clamp experiments were also performed on cultured 
human coronary smooth muscle cells (Fig. 6). The smooth muscle phenotype of 
these cells is demonstrated in the Supplement. The lower concentrations of BPA 
(1 and 10 µM) did not increase Maxi-K current; however, 100 µM BPA increased 
current significantly (Fig. 6B). Maxi-K current at +100 mV under control 
conditions was 843 ± 218 pA and increased to 1446 ± 393 pA with application of 
100 µM BPA (n = 6; p < 0.05). Based on concentration-response results with 
BPA in AD-293 cells expressing α or α + β1 subunits (Fig. 5), we investigated 
whether cultured human coronary smooth muscle cells expressed the β1 subunit. 
Thus, RT-PCR was used to analyze Maxi-K channel subunit mRNA expression. 
Cultured human coronary smooth muscle cells expressed KCNMA1 mRNA, but 
mRNA for KCNMB1 was undetectable (Fig. 6C). A positive control, using human 
brain cDNA, however, demonstrated the applicability of the KCNMB1 primers 
(Fig. 6C). Moreover, Western blots and immunocytochemistry experiments also 
failed to detect the β1 subunit in these cells (data not shown). Thus, the 
activation of Maxi-K channels in cultured human coronary smooth muscle cells 
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by a minimum concentration of 100 µM BPA is likely due to a lack of KCNMB1 
expression (Yang et al., 2009). 
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Discussion 
These studies demonstrate that BPA, an estrogenic endocrine disruptor, 
increases Maxi-K channel current via a nongenomic mechanism. The activation 
of Maxi-K channels by BPA depends, in a concentration-dependent manner, on 
the presence of the regulatory β1 subunit. Several lines of evidence support 
these novel observations. First, BPA-induced activation of Maxi-K channels was 
observed in freshly isolated and cultured coronary smooth muscle cells, as well 
as in AD-293 cells expressing cloned Maxi-K channel subunits. Furthermore, 
BPA increased Maxi-K channel NPo without affecting single channel 
conductance. Second, BPA-induced Maxi-K channel activation was detected in 
both whole-cell and single channel experiments. Moreover, results of the single 
channel studies clearly indicate that the effect of BPA is non-genomic, as the 
inside-out patches of membrane were removed from the cell. Third, the effects of 
BPA were rapid, reversible, and concentration-dependent. While we 
hypothesized that BPA activation of Maxi-K channels would depend on the 
presence of the regulatory β1 subunit, this prediction was upheld only partially by 
our studies. Specifically, the β1 subunit played a compulsory role in activation of 
Maxi-K channels by BPA when concentrations of 1 and 10 µM were tested; 
however, at a concentration of 100 µM, BPA activated Maxi-K channels without 
the β1 subunit. The latter finding suggests that the α subunit itself might be the 
target of BPA and that the β1 subunit simply enhances the response. The 
activating effect of BPA on Maxi-K channels and the transformative influence of 
the β1 subunit represent original observations of multifaceted mechanisms that 
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merit additional study. Because of the potential public health impact of BPA 
exposure and the fact that so many cell types express Maxi-K channels, the 
implications of these studies may be widespread. 
Previous studies document the activation of Maxi-K channels by 
estrogenic substances, including 17β-estradiol (Valverde et al., 1999). Thus, to 
find that BPA activates Maxi-K channels may not seem surprising at first glance. 
However, the lack of a relationship between the estrogenic nature of a compound 
and its effect on Maxi-K channels makes such presumptions difficult. For 
example, tamoxifen, an estrogen receptor modulator with mixed agonist and 
antagonist properties, activates Maxi-K channels more potently and efficaciously 
than 17β-estradiol (Dick et al., 2001). Moreover, the pure anti-estrogen ICI 
182,780 also activates Maxi-K channels (Dick, 2002). Studies generally agree, 
however, that the β1 subunit confers sensitivity upon Maxi-K channels to 
estrogens and xenoestrogens (Valverde et al., 1999; Dick et al., 2001; Dick & 
Sanders, 2001). Other steroid hormones, including androgens, also activate 
Maxi-K channels (Deenadayalu et al., 2001; Han et al., 2008). The role of Maxi-K 
channel β subunits, of which there are 4 known types, differs depending upon the 
agonist. For example, the β1 subunit is important for Maxi-K channel activation 
by 17β-estradiol (Valverde et al., 1999), while β2 and β4 subunits are important 
for responses to and discriminate between dehydroepiandrosterone and 
corticosterone (a stress-related adrenal androgen and a glucocorticoid, 
respectively) (Lovell et al., 2004; King et al., 2006). 
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It is clear that xenoestrogens impact not only the interaction of 17β-
estradiol with nuclear receptors (Krishnan et al., 1993; Kuiper et al., 1997), but 
also initiate nongenomic signaling mechanisms. For instance, BPA increases 
intracellular Ca2+ in GH3/B6 pituitary tumor cells (Watson et al., 2005; Wozniak et 
al., 2005; Watson et al., 2007) and pancreatic β cells (Alonso-Magdalena et al., 
2005). Elevated intracellular Ca2+ could explain the ability of BPA to activate 
Maxi-K channels; however, experiments in excised patches with solutions 
clamped to a known Ca2+ concentration eliminate the possibility of this 
mechanism in the present study. Additionally, while BPA activates signaling by 
protein kinases A and G in JKT-1 tesicular seminoma cells (Bouskine et al., 
2009) and these kinases are linked to Maxi-K channel activation (Kume et al., 
1989; Robertson et al., 1993), these mechanisms seem unlikely to explain our 
results. This is because ATP and other cofactors necessary for kinase signaling 
were absent in the excised patch studies. 
Thus, questions remain as to what mechanism(s) underlies the activation 
of Maxi-K channels by BPA. The same general uncertainty exists across the field 
for activation of Maxi-K channels by steroid hormones and their mimetics. At 
present, two types of data support the idea that an extracellular site of the β1 
subunit comprises at least a part of the binding domain for these compounds. 
First, membrane-impermeable conjugates of estrogen (Valverde et al., 1999) and 
tamoxifen (Dick et al., 2002) activate Maxi-K channels containing the β1 subunit 
from the extracellular, but not the intracellular, side of the membrane. Second, a 
putative binding site for steroid functional groups has been identified in the β1 
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subunit (Bukiya et al., 2007; Bukiya et al., 2008a; Bukiya et al., 2008b). Bukiya 
and colleagues show that lithocholate, a bile acid formed from cholesterol, 
activates Maxi-K channels containing β1, but not β4, subunits. Using a series of 
chimeric β1-β4 subunits, they demonstrate a region of the second 
transmembrane segment of the β1 subunit that may be particularly important for 
binding steroids. β1 subunits, however, are unlikely to be completely responsible 
for Maxi-K channel responses to steroids and xenoestrogens. Our data 
demonstrating differential BPA sensitivity of α or α + β1 Maxi-K channels support 
this concept. It seems possible that the α subunit could be the target of BPA and 
β1 subunits enhance BPA binding to the α subunit. In support of this idea, 
Korovkina and coworkers have demonstrated that the Maxi-K channel α subunit 
itself functions as a binding site for 17β-estradiol, and that β1 subunits enhance 
binding by approximately three-fold (Korovkina et al., 2004). Assuming that BPA 
may bind to the same site, their observations may explain why the β1 subunit, 
while not requisite for BPA-induced activation, increased the BPA-sensitivity of 
Maxi-K channels. The idea that the α subunit may be the target of BPA is further 
supported by the study of Perez suggesting that the tamoxifen binding site is 
located on the Maxi-K α subunit and that β1 subunits facilitate or stabilize the 
interaction (Perez, 2005). The possibility remains, however, that BPA interacts 
with an unknown molecule to transmit a nongenomic signal that activates Maxi-K 
channels. Further experiments are necessary to clarify the molecular 
mechanism(s) of BPA induced Maxi-K channel activation.  
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An important concern is relevance of the present findings in light of the 
levels of BPA exposure, and thus the concentrations of BPA measured, in 
humans. Worldwide, annual BPA production exceeds 6 billion pounds and 
hundreds of tons of BPA enter the atmosphere. Thus, it is surprising that data 
regarding BPA exposure levels remain scarce. Free unconjugated BPA in human 
serum ranges from approximately 0.9-90 nM (Vandenberg et al., 2007). Because 
free BPA is a minor fraction (5%) of the total BPA load (Csanady et al., 2002), 
total serum concentrations are estimated to be 0.017-1.7 µM. Nonetheless, BPA 
became a public health concern relatively recently and many controversies exist 
about routes of exposure, how much we are exposed to, mechanisms of BPA 
action, and associations with disease (Vandenberg et al., 2009). Our data 
obtained with micromolar concentrations of BPA appear to be higher than what 
most humans are exposed to; however, certain occupational populations are at 
much higher risk (Hanaoka et al., 2002). Much remains to be resolved about 
human exposure to BPA and its effects; however, we present the first evidence 
demonstrating that BPA affects ion channel function directly. 
In conclusion, we demonstrate that BPA activates Maxi-K channels in a 
nongenomic manner. This study focused on immediate effects of BPA on Maxi-K 
channel activity; however, further investigation will be required to determine any 
long-term effects of BPA exposure on ion channel function and expression. Our 
data indicate that the β1 subunit increases the BPA-sensitivity of Maxi-K 
channels; however, the α subunit alone is sufficient for the response of Maxi-K 
channels to BPA. The toxicology of BPA is not clear, but in cells that express 
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Maxi-K channels, activation by BPA would be expected to hyperpolarize the 
membrane potential. This would decrease excitability in cells that express other 
voltage-dependent ion channels; however, a more negative membrane potential 
would also increase the driving force for Ca2+ entry through open Ca2+ channels. 
Based on the present findings, it would be reasonable to suggest that BPA might 
act as a vasodilator through the opening of Maxi-K channels. Our findings 
represent the first known effects of BPA on an ion channel, but other types of ion 
channels should be studied to increase our understanding of BPA toxicity. 
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Fig. 1 BPA increases Maxi-K current in smooth muscle cells cultured from 
the canine coronary artery. (Panel A) Representative currents are shown under 
control conditions, with the application of 10 µM BPA, and with 1 µM penitrem A. 
(Panel B) Currents from a representative cell are shown under control conditions, 
with 1 µM penitrem A, and with 10 µM BPA in the continued presence of 
penitrem A. (Panel C) The voltage template used to elicit currents in this and 
subsequent figures. (Panel D) Group data (n = 5) demonstrate the BPA- and 
penitrem A-sensitivity of currents in cultured coronary artery smooth muscle cells. 
(Panel E) Penitrem A prevented BPA-induced increase in Maxi-K current (n = 4). 
Asterisks indicate p < 0.05 vs. control by one-way ANOVA. 
 
Fig. 2 BPA increases Maxi-K channel NPo in smooth muscle cells freshly 
isolated from the canine coronary artery. (Panel A) Representative 1 min 
recordings of Maxi-K channel activity in an inside-out patch before and after 
exposure to 10 µM BPA are shown. Patch potential was +80 mV and currents 
were recorded in symmetrical 140 mM K+ with 100 nM free Ca2+. BPA increased 
NPo, but had no effect on single channel amplitude. (Panel B) Group data (n = 10 
cells from 4 dogs) demonstrate that 10 µM BPA increases NPo. Asterisk indicates 
p < 0.05 by paired t test. (Panel C) Group data (n = 10) show that BPA has no 
effect on single conductance. 
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Fig. 3 Maxi-K β1 subunit confers sensitivity to 10 µM BPA. Currents were 
measured from AD-293 cells transfected with GFP (Panel A) and Maxi-K 
channels composed of α (Panel B) or α + β1 (Panel C) subunits. Voltage 
template used is shown in Fig. 1C. Very little whole-cell current was observed in 
cells expressing GFP only. Cells transfected with the α subunit demonstrate large 
outward currents with fast activation and little or no inactivation. Cells expressing 
α + β1 subunits demonstrate large outward currents with slower activation. 
(Panel D) Records from a representative cell transfected with the Maxi-K a 
subunit show that current is unaffected by 10 µM BPA, but blocked by 1 µM 
penitrem A. (Panel E) Current in a cell transfected with α + β1 subunits increased 
with application of 10 µM BPA and was blocked by 1 µM penitrem A. (Panels F & 
G) Group data illustrate the effect of 10 µM BPA and 1 µM penitrem A on current 
in cells expressing α (n = 11) or α + β1 (n = 7) subunits. Asterisks indicate p < 
0.05 vs. control by two-way repeated measures ANOVA. 
 
Fig. 4 BPA (10 µM) increases NPo of Maxi-K channels containing the β1 
subunit. Representative 1 s recordings of Maxi-K channel activity in inside-out 
patches from AD-293 cells expressing Maxi-K α (Panel A) or α + β1 (Panel B) 
subunits before and after exposure to 10 µM BPA. Patch potential was +40mV in 
symmetrical 140 mM K+ solutions containing 100 nM free Ca2+. (Panels C & D) 
contain all-points amplitude histograms from 1 min recordings of patches shown 
in Panels A & B. BPA increased the NPo of Maxi-K channels containing the β1 
subunit and no effect on single channel conductance. 
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Fig. 5 The activation of Maxi-K channels by BPA is concentration-
dependent and reversible. (Panel A) Maxi-K currents were measured in the 
whole-cell configuration after stepping membrane potential from -80 to +100 mV. 
Cells expressing Maxi-K channels composed of α or α + β1 subunits were 
studied (n = 7-12) under control conditions and after exposure to 1, 10, and 100 
µM BPA. Current was increased relative to control at all three concentrations in 
cells expressing α + β1 subunits; current was increased only with 100 µM BPA in 
cells expressing the α subunit alone. Asterisks indicate differences between α 
and α + β1 by two-way ANOVA. (Panel B) Maxi-K (α) and Maxi-K (α + β1) 
currents were elicited by stepping the membrane potential from -80 to +100 mV 
for 300 ms every 10 s. BPA (10 µM) was applied for 2 min and washed out. 
Current increased rapidly with exposure to BPA and returned towards baseline 
with washout (n = 4). (Panel C) Time course for the activation and the 
reversibility was normalized to the maximal activation of each value.  
 
Fig. 6 BPA, at a concentration of 100 µM, increases Maxi-K current in 
human coronary artery smooth muscle cells. (Panel A) Representative 
records demonstrate that BPA (100 µM) increased whole-cell current in smooth 
muscle cells cultured from human coronary arteries. (Panel B) contains group 
data (n = 3-7) for effect of three concentrations of BPA on Maxi-K current. (Panel 
C) RT-PCR revealed the expression of KCNMA1 (α subunit; 119 bp product) but 
not KCNMB1 (β1 subunit; 357 bp product) in cultured human smooth muscle 
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cells. Human brain cDNA was used as a control and the expression of KCNMA1 
and KCNMB1 was detected. –RT is a reaction without reverse transcriptase; 
NTC is a no template control. 
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Table 3 1 β1 subunit determines the response of Maxi-K channels to 10 µM 
BPA 
Subunit(s) Condition NPo Conductance (pS) 
α (n = 6) Control 0.75 ± 0.27 248 ± 8 
 BPA 1.06 ± 0.42 246 ± 9 
α + β1 (n = 6) Control 0.96 ± 0.11 253 ± 15 
 BPA 2.97 ± 0.58 (p < 
0.05) 
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Figure 3 6 BPA, at a concentration of 100 µM, increases Maxi-K current in 
human coronary artery smooth muscle cells 
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Supplemental information  
Cells from the canine coronary artery were cultured and differentiated into 
smooth muscle. Cells took ~4-5 days to start effectively dividing and grew to 
confluence in ~7 days. Cells no longer grew after passage ~10. Confluent cells 
exhibited a “hill and valley” pattern under phase contrast (Supplemental Fig. 1A). 
Immunoblots indicated the expression of smooth muscle-specific a actin and 
myosin heavy chain in differentiated cells (Supplemental Fig. 1B). Phase contrast 
images and smooth muscle-specific a actin and myosin heavy chain 
immunoreactivity for cultured human smooth muscle cells are also shown in 
Supplemental Figs. 1A & B. Smooth muscle cells were trypsinized and plated on 
cover glass for patch clamp experiments. These cells retained the smooth 
muscle phenotype, as shown by immunocytochemistry for smooth muscle-
specific α actin (Supplemental Fig. 2A). After treatment with differentiation media 
for 1 or 2 weeks, 75 ± 4 and 90 ± 3% of the canine cells retained the smooth 
muscle phenotype (n = 3, Supplemental Fig. 2B). Immunocytochemistry and the 
percent of cells with a smooth muscle phenotype are also shown in 
Supplemental Figs. 2A & B. Thus, canine coronary artery smooth muscle cells 
demonstrated morphology and immunoreactivity consistent with those observed 
by others in various species (Teng et al., 2006; Christen et al., 199. Taken 
together, we conclude that the majority of cultured cells possessed a smooth 




Western blots. Cultured cells were washed two times with PBS and 
harvested in RIPA lysis buffer supplemented with (mM) 2 PMSF, 1 Na3VO4, 1 
DTT and 1x protease inhibitor cocktail solution (Santa Cruz Biotechnology). 
Samples were sonicated on ice, incubated for 15 min on ice, and centrifuged at 
10,000 g at 4 °C for 10 min. The supernatant was removed and stored at -80°C 
until use. Protein concentrations were determined by BCA method using BSA as 
a standard (Pierce). Samples were diluted to 1 mg/ml in Laemmli sample buffer 
and boiled at 70 °C for 15 min. Equivalent amounts of protein were separated by 
SDS-PAGE, followed by electroblotting onto nitrocellulose membranes. 
Membranes were blocked with 5% nonfat milk (Bio-Rad) in TBST for 1 h at room 
temperature, washed 3 times in TBST, and incubated overnight at 4 °C in 
primary antibodies against smooth muscle α actin (1:500; Sigma), smooth 
muscle myosin heavy chain (1:500; Biomedical Technologies) and b tubulin 
(1:1000; Santa Cruz Biotechnology). After washing 3 times in TBST, membranes 
were incubated with anti-species secondary antibody conjugated with HRP and 
HRP-linked anti-biotin secondary antibodies for a biotinlyated ladder (1:5000; 
Cell Signaling Technology) for 1 h at room temperature and then washed again 3 
times with TBST. An enhanced chemiluminescence detection system (ECL 
Advance, Amersham Biosciences) was used to detect the antibodies and the 
lanes were analyzed using a G:Box system (Syngene).  
Immunocytochemistry. Differentiated cells were plated on cover glass and 
allowed to adhere overnight. Cells were washed with PBS and fixed in 4% 
formaldehyde in PBS, pH 7.4 for 30 min at room temperature. After three washes 
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in PBS, cells were permeabilized with 0.1% Triton X-100 in PBS for 2 min. Cells 
were treated 30 min in blocking solution (2% goat serum, 3% BSA in PBS) and 
then incubated with anti-smooth muscle-specific α actin (1:400; Sigma) for 1 h at 
room temperature in a humidified chamber. Following three washes with PBS, 
cells were incubated with Alexa Fluor 488-conjugated anti-mouse IgG (1:1000; 
Invitrogen) for 1 h at room temperature in a humidified chamber. After a final 
wash with PBS, cover glass was placed on mounting medium (Santa Cruz 
Biotechnology) on a slide. Images were obtained with an epifluorescence 
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Supplemental Fig. 1 Cells cultured from the canine LAD coronary artery 
revealed typical smooth muscle morphology and expressed smooth 
muscle phenotypic markers. (Panel A) Phase contrast images of cells cultured 
from the canine coronary artery develop over time into a characteristic “hill and 
valley” morphology. Human smooth muscle cell cultures are also shown. (Panel 
B) Immunoblot of smooth muscle-specific myosin heavy chain and α actin in 
canine and human cells. The expression of these smooth muscle markers 
increased over time in differentiation media. 
 
Supplemental Fig. 2 Smooth muscle cells plated for patch clamp 
experiments continue to express phenotypic markers. (Panel A) 
Immunofluorescence of smooth muscle-specific α actin (green) during 
differentiation; nuclei are stained blue. Images from canine and human cells are 
shown. (Panel B) The percentage of cells in culture that express smooth muscle-
specific α actin increases over time in differentiation medium (n = 3). Asterisks 
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Figure 3 7 Supplemental Figure 1. Cells cultured from the canine LAD 
coronary artery revealed typical smooth muscle morphology and 
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Figure 3 8 Supplemental Figure 2. Smooth muscle cells plated for patch 
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Background and purpose: Bisphenol A (BPA) is an estrogenic endocrine 
disruptor implicated in the development cardiovascular disease. We previously 
demonstrated that BPA activates smooth muscle BK (KCa1.1) channels non-
genomically (Asano et al. Br J Pharmacol. 160(1):160-70, 2010). This finding is 
seemingly inconsistent with BPA-induced cardiovascular disease. Importantly, 
however, estrogen also activates BK channels, but negatively regulates 
KCNMA1, the gene encoding BK channels. It is possible that BPA might have a 
similar effect; therefore, we tested the hypothesis that BPA reduces BK channel 
expression though a genomic mechanism. 
Experimental approach: Rat aortae were placed in tissue culture for a 48-72 
hour treatment with BPA (10 µmol/L). BK channel expression was determined by 
RT-PCR, Western blot, and whole-cell patch clamp. Experiments repeated with 
BPA in the presence of ICI 182,780 (1 µmol/L), an estrogen receptor antagonist. 
Key Results: BPA decreased the expression of BK α subunit mRNA and protein. 
Penitrem A-sensitive BK current was reduced in smooth muscle cells from BPA-
treated aortae. ICI 182,780, an estrogen receptor antagonist, blocked the effect 
of BPA to reduce BK channel mRNA, protein, and current. 
Conclusions and implications: These data indicate BPA decreases BK 
channel expression via activation of nuclear estrogen receptors. Further, our 
findings represent one potential mechanism by which BPA exposure may 
possibly be linked to cardiovascular disease.  
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Introduction 
Bisphenol A (BPA) is used to manufacture polycarbonate plastic, resin 
lining of cans, and dental sealants. Further, BPA is used as a non-polymer 
additive to other plastics. A number of recent studies support the idea that BPA 
may be associated with carcinogenesis, altered reproductive function, and 
developmental issues due to its estrogen mimetic properties (Wetherill et al., 
2005; Savabieasfahani et al., 2006; Vandenberg et al., 2007; Hugo et al., 2008). 
Thus, the FDA has some concerns regarding the effect of BPA, particularly in 
susceptible populations, such as fetuses, infants, and children. Recent 
epidemiological studies have revealed a significant relationship between urinary 
BPA concentration and cardiovascular diseases in the American adult population 
(Lang et al., 2008; Melzer et al., 2010). Furthermore, there is an association 
between erectile dysfunction and urinary BPA concentration in BPA-exposed 
workers (Li et al., 2010a; Li et al., 2010b). These studies suggest BPA-related 
pathologies may affect a much greater population, and altered vascular function 
with BPA exposure could be suspected, nonetheless; the mechanism of BPA 
action in vasculature remains unclear.  
We demonstrated that acute BPA exposure could activate large 
conductance, voltage/Ca2+-sensitive K+ (BK; KCa1.1) channels in vascular smooth 
muscle via a non-genomic mechanism (Asano et al., 2010). This non-genomic 
effect of BPA on BK channels was similar to that of estrogen and tamoxifen 
(Valverde et al., 1999; Dick et al., 2001). Estrogen has relevant genomic 
mechanisms as well, as it alters K+ channel expression in variety of tissues (Drici 
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et al., 1996; Roepke et al., 2007; Saito et al., 2009). BK channel expression in 
uterine smooth muscle was decreased in late pregnancy, when estrogen is 
highest (Song et al., 1999). Furthermore, long-term exposure to estrogen has 
been shown to directly interact with BK channels and down regulate BK channel 
expression in a heterologous expression system and human coronary artery 
smooth muscle (Korovkina et al., 2004). These studies demonstrate that BK 
channel is an estrogen-sensitive protein and it may be associated with BPA-
related cardiovascular pathologies. However, the effect of continuous exposure 
to BPA on functional BK channel expression vascular smooth muscle cells is not 
known. Therefore, this study examined whether BPA modulates BK channel 
expression in vascular smooth muscle cells and sought to determine the 
mechanisms. We hypothesized that BPA would alter BK channel expression 
through a mechanism that is dependent on interaction with classical estrogen 
receptors. To test this hypothesis, functional BK channel expression was 




Cell culture. A7r5 cells were purchased from American Type Cell Culture 
Collection (ATCC) and were cultured in DMEM supplemented with antibiotic (100 
U/ml penicillin G, 100 µg/ml streptomycin) and 10% fetal bovine serum. Cells 
were maintained at 37°C and 5% CO2 in a humidified incubator. The growth 
medium was replaced with phenol free DMEM (Invitrogen) supplemented 
antibiotic (100 U/ml penicillin G, 100 µg/ml streptomycin) and 10% fetal bovine 
serum.  
Tissue preparation and culture. The method previously described to 
culture arteries was utilized (Kleppisch et al., 1996). Briefly, aortae were collected 
from male Sprague Dawley rats (age 9-12 weeks) euthanized following unrelated 
experiments. Thoracic aorta was dissected and opened along its longitudinal axis 
in in low Ca2+ HEPES buffer containing (mM) 135 NaCl, 5 KCl, 0.36 CaCl2, 1 
MgCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. The aorta was cleaned of 
adventitia under the dissecting microscope and endothelial cells were removed 
by rubbing the lumen with cotton swab. After cleaning the tissue, aorta was cut 
into 3 pieces. These pieces of aortae were randomly placed in 35 mm dishes 
filled with phenol-free DMEM supplement with 0.5% BSA and antibiotics (100 
U/ml penicillin G, 100 ug/ml streptomycin). Cultured aortae were treated with 
0.1% DMSO, 10 µM BPA, and 10 µM BPA + 100 nM ICI 182780 for 2 days for 
mRNA expression assessment and for 3-4 days for protein function/expression. 
BPA (Sigma-Aldrich), estradiol (MP Biomedicals) and ICI 182,780 (Sigma-
Aldrich) were dissolved in DMSO and diluted 1:1000 for experiments. 
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Electrophysiology. Whole-cell patch clamp recordings were performed 
on single smooth muscle cells isolated from cultured rat aorta as described 
previously. In brief, solutions used in the recording conditions were a bath 
solution containing (mM) 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 
HEPES, and 5 Tris; pH 7.4. Pipette solution contained (mM) 140 KCl, 1 MgCl2, 1 
EGTA, 10 HEPES, 1 ATP, 0.1 GTP and 5 Tris and free Ca2+ 100 nM; pH 7.1. 
After the successful whole-cell configuration, ramp recordings from -100 to +100 
mV were performed until steady state whole-cell currents were observed.  
Immunoblotting, Western blot was performed using anti-ER alpha 
(1:250; NeoMarker RM-9101), ER beta (1:250; abcam ab3577), and BK channel 
α subunit (1:500; alomone lab) antibodies. The details of procedures were 
described previously (Asano et al., 2010). Rat ovary was used for the positive 
control for ERs in the western blot. For BK α subunits positive control, HEK cells 
were transfected with a plasmid encoding hSlo αβ1 (kindly provided by Dr. 
Lippiat from University Leeds) and these cell lysates were used as positive 
control.  
Reverse transcriptase polymerase chain reaction (RT-PCR). RT-PCR 
was performed as described previously (Asano et al., 2010). Details of primers 
and PCR condition are described in Table 1. 
Data Analysis. Results are presented as mean ± SEM. Data were 
analyzed using Prism software (GraphPad; San Diego, CA). Significant level was 
set at p<0.05.  
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Results 
Estrogen receptors in rat aorta. The mRNA and protein expression of 
ERs have been identified in varied types of vascular smooth muscle cells 
including different vascular beds, cultured, and species (Orimo et al., 1993; 
Karas et al., 1994; Freay et al., 1997). However, expression in our models (A7r5 
cells and cultured rat aorta) is unknown. We performed RT-PCR to conform ER 
expression in A7r5 cells and cultured rat aorta (Fig.1 A&C). Interestingly, different 
degree of expression of ER α and β were observed in A7r5 cell and cultured rat 
aorta. In order to further confirm the ER expression in our study model, we 
examined protein expression level by immunoblotting (Fig 1 B&D). Using rat 
ovary as a positive control, anti ER α antibody (NeoMarker RM-9101) detected 
an immunoreactive band around 64 kDa in A7r5 and cultured rat aorta. Similarly, 
anti ER β antibody (abcam ab3577) detected a prominent band around 52 kDa in 
these cells. These findings were consistent with other studies utilizing 
pharmacological approach to identify ERs in vascular smooth muscle cells 
(Bolego et al., 2005). Our RT-PCR and Western blot data indicated that A7r5 cell 
and cultured rat aorta express both ERα and β.  
Effect of BPA on BK channel expression. E2 has been shown to alter 
mRNA expression of BK channel α subunits (Song et al., 1999; Benkusky et al., 
2000; Eghbali et al., 2003; Jamali et al., 2003). RT-PCR data showed BPA 
altered BK channel α subunits mRNA levels in A7r5 cells (Fig2 A). To determine 
whether BPA altered the expression of BK channel α subunit protein content in 
rat vascular smooth muscle cells, immunoblot using Anti-BK channel α subunit 
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was performed. Using HEK cells overexpressed human BK αβ1 subunit as 
positive control, a prominent band around 125 kDa was observed in cultured rat 
aorta (Fig 2 A). Group data (n=7) indicated that BK α subunits content was 
reduced to 33.3 ± 7.9% of control in BPA-treated aortae (p<0.05). We tried 
several different anti- BK β1 subunits antibodies to examine whether BK β1 
subunit expression was similarly reduced by BPA, however, those commercially 
available anti BK β1 subunits antibodies could not detect endogenous level of BK 
β1 subunits expression (data not shown). Taken together, BPA decreased BK α 
subunit protein expression in rat aorta. 
ER antagonist prevents BPA-induced reduction in BK channel 
expression. In order to further examine the effect of BPA on the functional 
expression of BK channels, whole cell patch clamp recording were performed on 
vascular smooth muscle cells. Whole cell recordings from cultured rat aortic 
smooth muscle cells showed voltage dependent outward rectifying currents (Fig. 
3). Compared to aortic SMC treated with vehicle, whole cell current densities at 
100 mV were 57.2 ± 6.5 % lower in aortic SMC treated with 10 µM BPA (n=9 
from 3 different rats, p< 0.05) while whole cell current densities at 100 mV from 
aortic SMC treated with BPA + ICI were not different. (100.7 ± 13.9 % of control, 
n=14 from 5 different rats). Penitrem A (1 µM), BK channel antagonist, blocked 
66.6 ± 6.0 % of outward currents at 100mV in vehicle (0.1% DMSO) treated 
aortic SMCs with intracellular Ca2+ 100 nM (n= 9 from 6 different rats, p< 0.05). In 
BPA (10 µM) treated aortic SMCs, outward currents were blocked 40.0 ± 13.7 % 
by penitrem A (n=4 from 3 different rats, p< 0.05). Outward currents were 
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blocked by 68.8 ± 7.7 % by penitrem A from BPA+ ICI (100 nM) treated aortic 
SMCs (n=6 from 4 different rats, p< 0.05). Although we detected BK channel 
mRNA (Fig. 2 A) and protein (Fig. 2 B) in A7r5 cells and functional BK channel 
expression was reported in a previously (Si et al., 2006), we were unable to show 
any functional BK channel expression in A7r5 cells (thus no patch clamp data are 
shown). To determine the mechanism by which BPA reduced BK channel 
expression, we utilized a specific ER antagonist to test our hypothesis that BPA 
decreases BK channel expression via a genomic mechanism. Patch clamp whole 
cell recording indicated the mean penitrem A sensitive current density at 80 mV 
was 30.9 ± 5.61 pA/pF, 22.2 ± 2.47 pA/pF, 45.6 ± 8.29 pA/pF in DMSO, 10 µM 
BPA and BPA + 100 nM ICI, respectively (p< 0.05).  
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Discussion 
The purpose of this study was to examine the effects of long term BPA 
exposure on functional BK channel expression in vascular smooth muscle cells. 
Major findings of this study were: 1) BPA significantly decreased BK channel 
mRNA/protein expression in A7r5 cells and cultured rat aorta; 2) penitrem A-
sensitive BK channel currents in rat aortic smooth muscle were significantly 
diminished by BPA treatment; 3) BPA reduces BK channel expression through a 
mechanism depending up classical ER mediated signaling.  
The mechanisms by which BPA is associated with cardiovascular 
diseases are far beyond our understanding since the association between human 
BPA exposure and cardiovascular disease is a relatively recent public health 
concern. However, recent studies are attempting to shed light on some of the 
potential mechanisms. For instance, BPA in the nanomolar range can promote 
cardiac arrhythmias due to increased SR Ca2+ leak via mechanisms depending 
on different ERs based on gender (Yan et al., 2011; Belcher et al., 2012). 
Additionally, BPA in the micromolar range can alter atrial contractility via NO-
cGMP mediated mechanisms (Pant et al., 2011). Similarly, previous works by our 
laboratory have shown that the acute micromolar range of BPA exposure 
activates BK channel in canine and human coronary artery via non-genomic 
mechanisms (Asano et al., 2010). Finding that BPA was a BK channel opener did 
not readily fit with the idea that BPA is associated with cardiovascular disease; 
therefore, we decided to investigate longer exposure. In this study, we 
demonstrated 48-72 hr exposure to BPA decreased BK channel expression in 
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vascular smooth muscle via ER-mediated signaling. Taken together, these works 
may represent some of the possible explanations for the BPA associated altered 
vascular function seen in epidemiological studies (Lang et al., 2008; Melzer et al., 
2010; Melzer et al., 2012).  
Estrogen/BPA on BK channel expression. The functions of estrogen 
are quite complex, in that it is involved not only in classical reproductive function 
and cell growth, but also in other systems such as the cardiovascular system. 
Particularly, after the results of a long period of trial and error, the current 
perspective of hormone replacement therapy (HRT) is that it increases the risk of 
cardiovascular diseases. Therefore; HRT is no longer recommended for the 
prevention of cardiovascular diseases (Mosca et al., 2001; Rossouw, 2006). The 
mechanisms by which HRT increases the risk of cardiovascular diseases are not 
fully understood. One possibility may be E2 induced altered ion channel 
expression, which has been seen in a number of other studies (Ranki et al., 
2002; Kundu et al., 2007; O'Mahony et al., 2007; Kundu et al., 2008). Of those 
we were particularly interested in the BK channel since it plays a crucial role in 
vascular function (Nelson et al., 1995). 
Currently, there are several possible proposed mechanisms of alteration in 
BK channel current density via long-term E2 treatment (and presumably BPA 
exposure). One of them is that E2 causes alternative splicing to BK transcripts 
that causes fundamental changes to the BK channel’s properties such as Ca2+ 
and voltage sensitivity. This mechanism is supported by studies from England’s 
group showing that E2 and pregnancy induced up-regulation in both mRNA and 
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protein expression in mouse uterine smooth muscle cells, but diminished BK 
channel currents (Benkusky et al., 2000; Holdiman et al., 2002). In contrast to 
these data, a study by Toro and Stefani’s groups demonstrated E2 down-
regulates both BK channel mRNA and protein expression in rat uterine smooth 
muscle (Song et al., 1999). Furthermore, E2 regulates BK channel expression by 
different mechanisms depending on the species. Specifically E2 regulates BK 
channel surface expression by transcriptional regulation in rat myomerium, 
whereas membrane trafficking of BK channel is the major mechanism in 
regulation of BK channel surface expression in mice myometrium (Eghbali et al., 
2003). A final proposed mechanism is that the BK channel itself serves as an E2 
receptor and that E2 binding to BK channels triggers proteasomal degradation to 
decrease BK channel expression in human coronary artery smooth muscle cells 
(Korovkina et al., 2004). These data typify the complex effects of E2 on the 
regulation of BK channel expression, however, all these studies agree on one 
point; that long-term treatment of E2 decreases functional BK channel expression 
(Wang et al., 1998; Song et al., 1999; Benkusky et al., 2000; Holdiman et al., 
2002; Eghbali et al., 2003; Korovkina et al., 2004). Assuming BPA may regulate 
BK channel expression in the same way as E2 does due to its estrogenic 
properties, our results agree with these previous reports that demonstrated 
reduced BK channel current density with E2 exposure. Our data showed that the 
BPA-induced decreases in BK channel currents were most likely due to 
decreased protein expression in rat aorta.  
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It is reasonable to speculate that BPA acts similar to E2, as it is estrogenic; 
nevertheless, it is also possible that BPA uses totally different mechanisms that 
as of yet, have not been identified. Although our data demonstrate that a pure 
estrogen receptor antagonist (ICI 182, 780) reversed the BPA-induced decrease 
in BK channel function (suggesting ER-mediated signaling), we cannot rule out 
other possibilities such as membrane-initiated estrogen signaling (e.g. GPER 
activation) may regulate BK channel expression. BPA may also activate GPER 
mediated cell signaling, and addressing these membrane initiated signaling will 
require additional experiments. Further studies are needed to determine how 
other cell signaling pathways are involved in BPA-induced decreased in BK 
channel expression in vascular smooth muscle. 
 
Estrogen up-regulates BK channel function in uterine artery.  
In contrast to our data, E2 has been shown to reduce myogenic tone by 
mechanisms that depend on the up-regulation of BK β1 subunit, but not in α 
subunits in pregnant sheep uterine artery (Nagar et al., 2005; Hu et al., 2011). A 
similar study using uterine vascular smooth muscle from ewes showed that E2 
increased both BK α and β1 subunits mRNA/protein (Rosenfeld et al., 2009). We 
do not have data to explain the controversy, however, expression of BK channels 
by E2 is regulated differently in various species (Eghbali et al., 2003). 
Furthermore, some authors have mentioned that different mechanisms of BK 
channel α or β1 subunits up-regulation exist based on factors as seemingly trivial 
as branch orders of uterine arteries. Again, these results highlight the complex 
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effects of E2 on BK channel expression. In our experiments, we have tried 
several BK β1 subunit antibodies to analyze the β1 subunits expression levels, 
however, while those commercially available β1 subunit antibodies were able to 
detect overexpressed hSlo β1 and bSlo β1, they were inadequate for detection of 
endogenous BK β1 subunit expression. Therefore we do not know the effect of 
BPA on BK channel β1 expression in rat aorta. Based on this, it may be possible 
that several factors such as different vascular beds, sizes and species play a role 
in E2/BPA induced altered BK channel expression.  
A link between BPA exposure and BPA associated pathologies. Many 
studies have detected BPA in urine, blood and tissue, but the levels of BPA 
exposure are controversial. BPA has been shown to accumulate in adipose 
tissue (Nunez et al., 2001; Fernandez et al., 2007) so that the local BPA 
concentrations could be higher than the values reported in total blood. 
Furthermore, cumulative BPA exposure levels may play a role in BPA associated 
pathologies. Although these studies make it difficult to assess exact blood BPA 
levels, the BPA concentration we used (10 µM) is likely to be applicable to the 
occupational BPA exposure studies showing high levels of BPA exposure 
(Hanaoka et al., 2002; Li et al., 2010a). Interestingly, there was an over 4-fold 
increase in erectile difficulty that may suggest vascular dysfunction in BPA 
exposed workers than non-exposed workers (Li et al., 2010a). According to our 
findings, BPA-induced decreased functional BK channel expression in vascular 
smooth muscle may be the one of plausible mechanisms.  
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Although it is beyond the scope of this study, much attention has been 
given to the effects of BPA exposure on the development of fetuses, infants and 
young children. It has been demonstrated that Drosophilia slowpoke (dSlo; 
homologous to human KCNMA1) gene expression is precisely regulated based 
on specific cell types and developmental periods for the normal development 
(Brenner & Atkinson, 1996; Chang et al., 2000). Whether BPA alters BK channel 
expression during development periods is not determined yet. Additional 
experiments regarding BPA toxicity on ion channels will add to our understanding 
of the link between BPA exposure and BPA associated pathologies.  
In summary, we demonstrate that BPA reduces BK channel expression in 
vascular smooth muscle. Given that estrogen regulates BK channel expression, 
this effect of BPA on BK channel expression is likely to be an estrogenic property 
of BPA. The mechanisms by which BPA reduced BK channel expression 
involved in classical ERs and nuclear signaling pathways. The findings are novel 
because they represent the firs known effects of BPA on ion channel expression 
in any tissue. Additional studies designed to examine in vivo effects of BPA on 
BK channel expression; as well as to explore other potential ion channel targets 
will be necessary to increase our understanding of the clear explanation of the 
association of urinary BPA levels and cardiovascular diseases. 
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Figure legends 
Fig. 1. Cultured rat aorta and A7r5 cells express estrogen receptors. A.B) 
mRNA expression levels of ERs from A7r5 cells and cultured aortas were 
analyzed by RT-PCR. C,D) Protein expression levels of ERs were determined by 
immunoblotting. A rat ovary was used as a positive control for RT-PCR and 
Western blot.  
 
Fig. 2. BPA reduces BK channel expression. A) A picture of RT-PCR data 
from different doses of BPA treated A7r5 cells. B) Whole cell lysates obtained 
from A7r5 cells treated with different doses of BPA were analyzed by 
immunoblotting with Anti-BK channel α subunit antibody. Group data normalized 
to SM α-actin showed BPA decreased BK channel expression from A7r5 cells in 
a concentration-dependent manner (n=8). C). Proteins isolated form cultured rat 
aortae were analyzed by immunoblotting with Anti-BK channel α subunit 
antibody. Group data indicated 10 µM BPA decreased BK channel expression (n 
=7). An asterisk (*) indicates significant difference from vehicle treated sample. P 
< 0.05. 
 
Fig. 3. BPA decreases functional BK channel expression in cultured rat 
aorta. Functional BK channel expressions from BPA treated cultured aorta were 
analyzed by patch clamp whole cell recordings. Currents were elicited by using 
the voltage template shown. Penitrem A, a selective BK channel antagonist, was 
utilized to identify BK channel currents. A~C) Representative current traces and 
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IV relationship from vehicle (0.1% DMSO), 10uM BPA, and 10uM BPA +100nM 
ICI (ERs antagonist) treated rat aorta. An asterisk (*) indicates significant 
difference from penitrem A (P < 0.05). 
 
Fig. 4. ER antagonist (ICI 182,780) abrogates effect of BPA on BK channel 
expression A). Representative penitrem A-sensitive currents from each 
treatment. Group data (n=4 each group) from penitrem A sensitive currents 
demonstrated BPA significantly decreased BK channel currents and pretreatment 
with an ER antagonist prevented BPA induced decreased BK channel 
expression. P < 0.05. B). Western blot data indicated BPA decreased BK channel 
protein contents and that ICI pretreatment blocked this effect. An asterisk (*) 





Table 4 1 Primers used for the RT-PCR analysis 
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The purpose of this dissertation was to determine whether BPA modulates 
vascular BK channel function and expression. Furthermore, we wanted to 
determine the mechanisms of BPA-induced reduction in BK channel function and 
expression. Our long-range goal was to identify molecular mechanisms by which 
estrogenic chemicals affect vascular function. Our objective was to determine 
mechanisms by which BPA modulates BK channel expression and function. The 
central hypothesis was that BPA alters BK channel expression and function 
through separate genomic and non-genomic mechanisms. The rationale was that 
receptors for BPA exist at both the cell membrane and in the nucleus. 
Human BPA exposure and cardiovascular disease became public health 
concerns relatively recently; furthermore, we do not understand whether a cause 
and effect relationship exists in the association of BPA exposure and 
cardiovascular diseases seen in epidemiological studies. We chose ion channels 
for the possible target protein for the effects of BPA. Specifically, we selected BK 
channels as a target molecule since it is expressed in a variety of tissues and 
involved in a variety of cellular functions (Ahluwalia et al., 2004; Ruttiger et al., 
2004; Meredith et al., 2006; Pyott et al., 2007; Grimm et al., 2009) and plays an 
important role in vascular tone. Since the gold standard BK channel antagonist, 
IBTX, has experimental limitations such as cost and membrane impermeability, 
we reasoned that the characterization of an economical pharmacological 
alternative would facilitate the study of BK channels. Thus, our initial experiments 
have systematically characterized the effect of penitrem A, a tremorgenic 
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mycotoxin, on BK channels and demonstrate the role of BK channels in the 
vascular function of mice (Chapter 2). Our data demonstrated that whole cell 
currents from HEK 293 cells transfected with hSlo α or α + β1 were effectively 
blocked by penitrem A (IC50 7 vs. 107 nM; p<0.05). The inhibitory effects of 
penitrem A (50.4 ± 9.38 %) and IBTX (49.7± 9.44 %) on K+ currents were the 
same degree in coronary artery smooth muscle cells. As for specificity, penitrem 
A had no effect on Kv1.5 currents and pinacidil-induced vasodilation. Finally, in 
vivo hemodynamic response indicated that penitrem A significantly augmented 
phenylephrine induced increases in mean arterial blood pressure by blocking BK 
channel in mice (p<0.05). Taken together, our data indicated that penitrem A is 
an excellent tool to study BK channel in vascular function and is not only practical 
for cell/tissue in vitro studies, but also for whole animal in vivo vascular functional 
studies. 
Next, we wanted to determine the effect of BPA on BK channels using 
penitrem A. Our data showed that BPA increased BK channel currents and BK 
channel β1 subunits facilitated BK channel’s sensitivity to BPA (Chapter 3). This 
was determined by whole cell recording showing greater outward current with 
acute BPA exposure in cultured CCASMCs and HCASMCs. Single channel 
recording from freshly isolated canine LAD revealed that BPA increased NPo of 
BK channel. Based on these findings from cultured cells and freshly isolated 
cells, we next performed the patch clamp experiments on BK channels 
exogenously expressed on the cells that do not express BK channels 
endogenously. In these experiments, cells transected with BK α and β1 subunits 
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revealed a significant increase in BK channel current and greater NPo when cells 
were exposed to 10 µM BPA. In contrast, cells with BK channel α subunits alone 
showed no significant increase in BK outward currents or NPo. Given that 
several steroid hormones activate BK channel via β subunits (Valverde et al., 
1999; Lovell et al., 2004; King et al., 2006), it is possible that xenoestrogens also 
may be associated with β subunit dependent BK activation. These findings are 
important as they should serve as additional evidence that the xenoestrogen, 
BPA, activates BK channels and the role of BK β subunits on steroid hormones 
and xenoestrogens induced BK activations. Non-genomic effect of BPA on BK 








Figure 5 1 Non-genomic effect of BPA on vascular BK channel. 
BPA can activate BK channel independent of changing intracellular Ca2+ levels. 




The effects of long-term exposure to BPA on BK channel expression were 
assessed on A7r5, rat aortic cell lines, and cultured rat aorta. In this part of the 
study (Chapter 4), we hypothesized that BPA would decrease BK channel 
expression through estrogen receptor dependent signaling. The principle behind 
this hypothesis was that BK channel gene expression and functional protein 
expression from uterine smooth muscle cells are known to be estrogen-sensitive. 
(Wang et al., 1998; Song et al., 1999; Benkusky et al., 2000; Holdiman et al., 
2002; Eghbali et al., 2003; Korovkina et al., 2004). Given that BPA possesses 
estrogenic properties, we tested whether BPA altered BK channel expression in 
rat aorta. Our data indicated that BPA altered BK channel transcript from A7r5 
cells and decreased protein expression levels in A7r5 cells and cultured rat aorta. 
The mechanisms of BPA induced decreased BK channel expression depended 
on classical estrogen receptor signaling, as confirmed by an estrogen receptor 
antagonist that inhibits BPA’s effects on BK channels. Taken together, our data 
suggested that long term BPA exposure decreased BK channel expression via 
genomic mechanisms. The genomic effect of BPA on vascular BK channel 









Figure 5 2 Genomic effect of BPA on vascular BK channel.  
BPA can activate BK αβ1 channels at the plasma membrane. Additionally, BPA 
can interact with ERs to regulate BK channel α subunit expression. ER 
antagonist, ICI 182, 780 can prevent the effect of BPA to reduce BK channel α 
subunit expression.  
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It is important to mention some limitations of this study. In order to assess 
the genomic and nongenomic effects of BPA on the BK channel, multiple model 
cells were utilized. Specifically, nongenomic pharmacological properties of BPA 
were elucidated using cultured and native vascular smooth muscle cells, as well 
as cloned BK channels, including: cultured canine coronary smooth muscle cells, 
cultured human coronary artery smooth muscle cells, cloned bovine BK channels 
expressed in HEK 293 cells, and native canine coronary artery smooth muscle 
cells. The reason we used so many different cell types over time was basically 
due to comments from grant and manuscript reviewers (e.g., previous results 
were in canine cells, so reviewers asked us to establish a canine cell culture 
model). Further, we chose human coronary cells for relevance, but abandoned 
the model due to cost. We realize that having this number of model cells can be 
distracting; however, similar results from multiple cell types strengthened our 
conclusion that BPA activated BK channels through a non-genomic mechanism 
depending on the β1 subunit. The genomic effects of BPA on BK channels were 
tested in A7r5 cells (a neonatal rat aortic cell line) and smooth muscle from tissue 
cultured rat aorta. Given that the expression of BK channel by estrogen is 
regulated in different ways based on species, we limited our model system to rats 
for the genomic studies. It is possible that the effect of BPA on BK channel 
expression may be different in other species. Although our study demonstrate 
that BPA decreased BK channel expression via ERs, it is possible that BPA may 
utilize other mechanisms in reducing BK channel expression (e.g., proteosomal 
degradation). Since the genomic and nongenomic mechanisms of BPA’s effects 
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on BK channel were elucidated in different models, a criticism could be that each 
mechanism is model-specific. Importantly, however, we demonstrated both 
genomic and non-genomic mechanisms of BPA in rat aorta, suggesting that the 
results can be generalized to other smooth muscle.  Whether both genomic and 
non-genomic effects are relevant to human BPA exposure needs to be examined 
in future studies. 
Given that BPA is detected in over 95 % of the US population and similar 
findings have been reported world wide, there is little doubt that some level of 
BPA is in virtually everyone's system. One important question that needs to be 
addressed is whether the levels of BPA exposure to the general population are 
significant for cardiovascular disease. Table 1 was derived from a review study 
by Vandenberg LN et al (Vandenberg et al., 2007). The majority of 
epidemiological studies indicated geometric mean urinary BPA ranges from 
1.12~27.3 ng/ml. Based on these studies, the current consensus regarding 
human BPA exposure levels is in the parts per billion levels (vom Saal et al., 
2007). Recent data of urinary BPA levels from US NHANES (2003/2004 and 
2005/2006) are also within these ranges (2.6 ug/L (Calafat et al., 2008), 2.49 
ng/ml, (Melzer et al., 2010)) and data from the European Prospective 
Investigation of Cancer (EPIC) were median urinary BPA 1.3 ng/ml (Melzer et al., 
2012). 
Interestingly, there is a BPA pharmacokinetic study on human subjects 
that directly measured both blood and urinary BPA levels (Volkel et al., 2002). 
The study demonstrated that peak blood d16-BPA-glucuronide was approximately 
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6-fold higher than urinary d16-BPA-glucuronide after consuming radiolabeled BPA 
(5 mg/person).  Furthermore, local BPA concentration could also be higher 
because BPA can be stored in adipose tissue and it has been suggested that it 
leaches from adipose tissue (Nunez et al., 2001; Fernandez et al., 2007b). Thus, 
it is difficult to assess how accurately these urinary BPA levels reflected blood 
BPA levels. On the other hand, in factory workers who are exposed BPA 
because of their occupation, median urinary BPA concentrations were 84.6 µg/g 
Cr (He et al., 2009), 57.9 µg/g Cr (Li et al., 2010) and this population had over 
20-30 times more exposure compared to the general population (2.6 µg/g Cr, US 
NHANES) (Calafat et al., 2008) 
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Table 5 1 Studies measured urinary BPA  
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Based on these studies regarding the level of human BPA exposure, our 
studies using a micro molar range of concentration were applicable to the 
occupationally exposed populations, but probably not to the general population. 
Similar to our study, the micro molar range of BPA exposures has been shown to 
decrease atrial contractility in rat heart due to the alteration of NO-cGMP 
signaling (Pant et al., 2011). Our studies examined only BK channels based on 
the estrogen sensitive properties of BK channels, however, it is possible that 
other proteins may be particularly susceptible to BPA, and may alter 
cardiovascular function. Indeed, recent studies indicated that exposure levels 
relevant to the general population, in the nano molar range of BPA, have been 
shown to alter Ca2+ handling in cardiac myocytes, promoting arrhythmic events in 
rodent hearts (Yan et al., 2011; Belcher et al., 2012). In order to address the link 
between BPA exposure and cardiovascular events, further investigation is 
required to answer the molecular mechanisms of BPA's effect. 
Whether these BPA-induced changes in vascular BK channel function and 
expression directly link to the association of BPA exposure and cardiovascular 
diseases are currently unclear, our data are the first evidence to describe that 
BPA modulates vascular BK channel function and expression via genomic and 
non-genomic mechanisms. Further studies are needed to determine if BPA 
affects other ion channels that have roles in regulating vascular function.  
 
Future directions:  
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Multiple aspects regarding the mechanism of action for BPA toxicology will 
be opened to scientists in this field. First, it would be interesting to determine 
whether there is a critical time or point of exposure that is associated with the 
development of cardiovascular disease. Does prenatal exposure eventually lead 
to cardiovascular disease in later life? How much exposure and over what time 
period is required to see the development of cardiovascular disease? Does in 
vivo exposure to BPA reduce BK channel expression in VSMC and alter vascular 
reactivity? Second, is it possible that BPA modulates the function and expression 
of other ion channels? Since steroid hormones alter Ca2+ channel expression 
and function (Er et al., 2007; Ullrich et al., 2007; Sarkar et al., 2008) it will be 
interesting to determine whether BPA possesses similar properties. Lastly, are 
there population-specific effects of BPA? Are females more susceptible to BPA-
associated disease due to the importance of estrogen signaling? Do endogenous 
estrogen levels influence the toxicological effects of BPA? Additionally, since 
BPA is lipophilic and accumulated in adipose tissue, (Fernandez et al., 2007a), is 
the obese population affected by a higher level of BPA? These interesting 
studies will require an initial characterization and a certain level of understanding 
of BPA’s interaction with other molecules. Our study provided novel evidence 
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